DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGLC6; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; IGHV1-45; TRBC2; IGHA2; IGHV1-3; IGHV3-35; IGHV1-18; IGHG4; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGHV2-5; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	54	99	54.5454545454545	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; FCN1; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	60	92	65.2173913043478	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV1-45; IGHV3-21; IGHV5-51; IGHV3-20; IGHV3-35; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGLL5; IGHV4-28; IGHV2-26; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV3-64; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	90	161	55.9006211180124	0	0	0	0	0	0	0
up	TNFRSF13B; LILRA1; IFNG; IL2RA; CD3D; CD3G; SAG; CXCR1; KLRC1; CXCR3; CCR5; ADGRE1; LILRB2; CLEC1A; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; TRBV6-1; TRBV7-1; TRBV27; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV5-3; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	65	268	24.2537313432836	0	0	0	0	0	0	0
up	LYZL6; HP; ELANE; IRF8; CEBPE; TLR9; STAB1; TREM2; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-53; IGHV3-13; IGLC6; IGHV1-24; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHV1-45; IGHA2; IGLC2; IGHV3-72; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV1-58; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-35; IGHV3-23; IGHV1-69; IGHV1-69-2; IGHV4-31; IGLC7; TRDC; IGHV3-20; IGHV4-61; IGHV3-43; IGKC; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	62	216	28.7037037037037	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; TRAV19; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; TRAV29DV5; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC6; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; TREML2; LAIR2; CLEC4G; TREML4; CD300LD; LILRB2; LILRB1; CD300LF; KIR2DL4; TREM2; CD300A; SIGLEC7; BTNL8; BTNL3; BTN1A1; HHLA2;	GO:0050776~regulation of immune response	97	216	44.9074074074074	0	0	0	0	0	0	0
up	TLR9; IGHV1-45; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGHG4; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGLC6; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-35; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	55	98	56.1224489795918	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; JCHAIN; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; GYPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; GYPB; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; DBH; CD48; IGLC6; IGLC2; IGLC3; IGHV1-2; CEACAM8; CEACAM3; IGLV3-21; ANGPT1; SIRPG; CD84;	GO:0050900~leukocyte migration	67	193	34.7150259067358	0	0	0	0	0	0	0
down	HOXC11; TBX1; GLI2; GLI3; HOXB1; NR2F2; HOXD10; HOXD3; HOXA11; HOXC8; HOXC13; PCGF2; HOXD13; MSX2; HNF1B; LHX1; EMX2; BMPR2; ALX1; ARC; SCMH1; SMO; ALX4; HIPK2; HOXC10; CELSR1; VANGL2; HOXC6; HOXC5; HOXA4; HOXA6; HOXA5; HOXB6; HOXD9; HOXB7; LRP5; HOXC4; HES1; LRP6; HOXC9; HOXD4; HES2; HES7; HOXA3;	GO:0009952~anterior/posterior pattern specification	44	99	44.4444444444444	0	0	0	0	0	0	0
down	TNFRSF11B; AGRN; LAMA5; MATN3; PDGFB; COL2A1; COL4A1; FN1; PDGFA; APP; SERPINE1; ITGB1; COL5A2; ITGAV; LAMB1; THBS1; COL4A2; HAPLN1; LAMC1; ELN; ITGB4; ITGA2; ERCC2; ITGB6; NF1; TNC; LAMA1; ITGA3; COL4A5; FBN2; KDR; SOX9; LUM; ITGA8; MFAP2; WNT3A; HSPG2; COL7A1; COL16A1; DDR1; CD47; FOXF1; FOXF2; LAMB3; LAMC2; COL4A6; LAMA3; SH3PXD2A; EGFLAM; ADAMTSL2; PXDN; APBB2; ICAM5; NR2E1; COL27A1; MMP2; COL17A1; COL15A1; MMP12; MMP13; TGFBI; COL22A1; MMP10; MMP7; MMP16; MMP14; MMP17; MMP15; MMP19; POSTN;	GO:0030198~extracellular matrix organization	70	230	30.4347826086957	0	0	0	0	0	0	0
down	TERT; DDAH1; PAK4; SERPINE1; FGF1; ITGB1; THBS1; RRAS; F3; AQP1; CDH5; APLNR; KDR; WNT5A; GATA4; CCL11; HMGA2; ISL1; CX3CL1; SEMA5A; TWIST1; PTGIS; CCBE1; ADM2; GATA6; ANGPTL4; HIPK2; SPHK1; NR2E1; VEGFC;	GO:0045766~positive regulation of angiogenesis	30	131	22.9007633587786	0.00011228502916649	0.00891204738343365	0.642494936890669	0.650579458990656	0.559291730278298	0.642494936890669	0.0823640736922177
down	TERT; NRP1; WFS1; HRAS; JUN; NEFL; EN2; MDK; GABRB3; AXL; GDNF; GABRB2; DLX1; ISL1; STXBP1; EN1; BAX; GRIK2; NFATC4; SIX1; ITSN1; SNCB; TFAP2B; VSTM2L; FAIM2; HIPK2; NRBP2; SIX4; APOE; NTF4; NTF3;	GO:0043524~negative regulation of neuron apoptotic process	31	138	22.463768115942	0.00011780078651402	0.00910050342749657	0.673820498860205	0.682537757062242	0.574632236615398	0.673820498860205	0.0841057618625247
down	NRP1; LAMA5; SEMA7A; ABL1; APOA1; ITGB1; ITGAV; ITGA2; ITGA3; ITGA8; BCAR1; DST; COL16A1; CD47; CDH17; DOCK1; FERMT2; FERMT1; FUT8; ADAMTS1; ITGBL1; ITGB6; ITGB4; LAMA3;	GO:0007229~integrin-mediated signaling pathway	24	96	25	0.00017202244591374	0.0125007856732316	0.983280300842962	0.996698051624234	0.681208885818427	0.983280300842962	0.115530762809295
up	TRPM2; GATA1; FLT3; LILRB1; BATF3; TREM2;	GO:0097028~dendritic cell differentiation	6	12	50	0.00019290245564196	0.0184096039188743	0.419177036109986	0.42342089013411	0.418791231198703	0.419177036109986	0.152272843719105
down	GRXCR2; SRRM4; TBX1; SPRY2; SNAI2; WFS1; CNTN5; COL2A1; TFAP2A; TH; PAX3; GABRB3; GJB2; GABRB2; ALDH7A1; HOXA1; ROR1; CRYM; SIX1; CEACAM16; PGAP1; NAV2; MYO3A; SLITRK6; EPS8L2; ATP6V0A4; SLC52A3; MYO1A; DCDC2; USH1C; PDZD7;	GO:0007605~sensory perception of sound	31	143	21.6783216783217	0.00020339704113825	0.0141985838115065	1	1	0.728208364095807	0.999999950762617	0.131221609699912
down	MATN3; WFS1; PRSS23; FSTL3; TSPAN15; APOA1; APOE; FN1; APP; APOA4; LAMB1; MMP2; MELTF; LGALS1; PGA3; PGA5; LAMC1; HRC; IGFBP6; TNC; ADORA2B; MMP13; HSPG2; MFGE8; FSTL1; GAS6; PDIA6; TGFBI; IGFBP7; TMEM132A; NOTUM; AMTN; HIST2H3A; SFTPA2; FAM20C; PCSK9; GATA6; PAPPA2; EVA1A;	GO:0044267~cellular protein metabolic process	39	200	19.5	0.0002332076931506	0.015896533813113	1	1	0.763824516929744	0.999999950762617	0.146913860093237
down	DLL1; TBX3; CCND1; SOX9; CAV1; OSR1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	7	9	77.7777777777778	0.00027106479227356	0.0180522920279661	1	1	0.805545791224226	0.999999950762617	0.166837119119083
down	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	7	9	77.7777777777778	0.00027106479227356	0.0180522920279661	1	1	0.805545791224226	0.999999950762617	0.166837119119083
down	MGST3; CYP26A1; UGT1A9; CBR3; AKR7A3; CYP2C9; NQO1; UGT1A6; AADAC; CYP2F1; FMO3; CYP2C18; CYP2C19; HNF4A; RORC; BPHL; AKR7L; CMBL; FMO2; GSTA1; CYP2S1; CYP2U1; GSTA3;	GO:0006805~xenobiotic metabolic process	23	94	24.468085106383	0.00030227924033521	0.0194643063053024	1	1	0.832477027883175	0.999999950762617	0.17988678582184
down	FOXH1; GATA4; ISL1; TGFB2; JAG1; SOX4; PPP1R13L; SEMA3C;	GO:0003215~cardiac right ventricle morphogenesis	8	13	61.5384615384615	0.00030906389024643	0.0194643063053024	1	1	0.838181270348319	0.999999950762617	0.17988678582184
down	NF1; CTNNB1; ID4; DLX1; DLX2; HES1; TMEM98; DUSP10;	GO:0048715~negative regulation of oligodendrocyte differentiation	8	13	61.5384615384615	0.00030906389024643	0.0194643063053024	1	1	0.838181270348319	0.999999950762617	0.17988678582184
down	CYP1A1; ITGA2; CPS1; HNF1B; HNF4A; PROX1; E2F7; PCK1;	GO:0070365~hepatocyte differentiation	8	13	61.5384615384615	0.00030906389024643	0.0194643063053024	1	1	0.838181270348319	0.999999950762617	0.17988678582184
down	ZNF609; LAMA5; TBX1; SGCE; CXCL10; DMD; PAX3; SRI; ETV1; MAPK12; SMTN; EVC; SGCG; TWIST1; SPEG; ZFHX3; SGCB; CTF1; BVES; TCF12; ALX4; CHODL;	GO:0007517~muscle organ development	22	89	24.7191011235955	0.00035870854252484	0.022347927907408	1	1	0.874890135218094	0.999999950762617	0.206536871028725
up	HBZ; HBD; HBG1; HBG2; HBA1; HBM;	GO:0015671~oxygen transport	6	14	42.8571428571429	0.0003687315515527	0.0323746302263274	0.800516198420919	0.809365755658184	0.745026754634587	0.800516198420919	0.267782893681006
down	GPR37; TBX1; SORBS3; BCAR3; HRAS; PDGFB; PDGFA; BMP2; ADRA2B; ADRA2C; IL11; EFNA1; SHC1; RYK; CTNNB1; ADRA1B; KDR; CAV2; NDST1; CX3CL1; DAB2IP; LPAR1; C1QTNF1; ROR1; IGF1R;	GO:0043410~positive regulation of MAPK cascade	25	109	22.9357798165138	0.00039222604245126	0.0239216598943432	1	1	0.896348634283631	0.999999950762617	0.221081113419612
down	SERPINE1; KRT16; TPM1; RRAS; MIF; NF1; STC1; SLURP1; CX3CL1; JAG1; IL24; DPYSL3; KANK1; PTPRK; SHH; PIP5KL1; SFRP1; DLG5; PTPRU; DLC1; TBX5; PLXNB3; NISCH; ROBO1; DUSP10; SRGAP1;	GO:0030336~negative regulation of cell migration	26	116	22.4137931034483	0.00041112424359335	0.0244385206572186	1	1	0.905597469081355	0.999999950762617	0.225857878637582
down	HOXB7; GDNF; SOX9; LHX1; SIX1; SMO; LGR4; SIX4; MAGED1;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	9	18	50	0.00041722466364746	0.0244385206572186	1	1	0.908114776429602	0.999999950762617	0.225857878637582
down	PDLIM1; NPHP1; FLNB; ABL1; PDGFA; NF1; PFN2; RAC3; FGD1; KANK1; FSCN1; INF2; FGD6; PALLD; ARPC1A; ARHGEF17; DLC1; NISCH; MICALL2; SHROOM2; SPECC1L-ADORA2A; SMTNL2; SMTN; PDLIM4; CAPZA3; ARFGEF3; ARHGEF10; PDLIM3; CSRP3; MICAL3; AMOTL1; EHBP1;	GO:0030036~actin cytoskeleton organization	32	157	20.3821656050955	0.0004175722376708	0.0244385206572186	1	1	0.908219616934	0.999999950762617	0.225857878637582
down	UGT1A9; UGT2B7; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	8	14	57.1428571428571	0.0004472490440156	0.0256570392180835	1	1	0.920540182885773	0.999999950762617	0.237119281121704
down	NFIB; SNPH; UNC5C; BAG3; COL4A1; APOD; NF1; SYT1; PTPRG; AK4; SMARCA1; ITGA8; FOXG1; HSPG2; DLX2; ADCY1; SHROOM2; BMPR2; ITSN1; BAK1; VAX1; DMBX1; CTTNBP2; PROX1; SRR; SMG9; SLC6A17; ROBO2; SPHK1; H2AFY2; CDH22; NDRG4; EMX2; PAFAH1B3; AMIGO2; ZFHX3; PAFAH1B2; SCTR; ADGRL3; ADGRL2;	GO:0007420~brain development	40	217	18.4331797235023	0.00052514897300703	0.0284365714916148	1	1	0.945768192411736	0.999999950762617	0.262807385230373
down	NRP1; PDGFB; ITGA2; S100A11; POSTN; P2RY6; SEMA6D; HAS2; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	9	19	47.3684210526316	0.0005657399515272	0.0297990661740781	1	1	0.955534778129441	0.999999950762617	0.275399397772885
down	WNT9B; TBX3; WT1; BMP5; CTNNB1; HOXD13; SHH; LGR4; ASB1;	GO:0030539~male genitalia development	9	19	47.3684210526316	0.0005657399515272	0.0297990661740781	1	1	0.955534778129441	0.999999950762617	0.275399397772885
down	EPHA2; WNT5A; WNT3A; TCF15; SP5; HES7; TP63; FZD3; VANGL2;	GO:0036342~post-anal tail morphogenesis	9	19	47.3684210526316	0.0005657399515272	0.0297990661740781	1	1	0.955534778129441	0.999999950762617	0.275399397772885
down	DCLK1; TRIO; COL2A1; GABRA4; ATN1; NHLH2; SHH; UGT8; ANKLE2; DNER; DMBX1; NRCAM; JARID2; KLK6; ROBO2; CELSR1; TAGLN3; RPS6KA6; TBX2; HAPLN1; VAX2; EMX2; ZIC5; SMO; VAX1; SOX9; TBX3; SPINK6;	GO:0007417~central nervous system development	28	133	21.0526315789474	0.000598355297308	0.0306802707309964	1	1	0.9634056714225	0.999999950762617	0.283543384664028
down	ITGB1; INHBA; ITGB4; ITGA2; ITGA3; HMGA2; ITGA8;	GO:0048333~mesodermal cell differentiation	7	11	63.6363636363636	0.00064098761412367	0.0312916972703772	1	1	0.973660185853867	0.999999950762617	0.289194115453516
down	PLXNA2; COL2A1; SOX9; WNT3; SOX4; SHH; SEMA3C;	GO:0060174~limb bud formation	7	11	63.6363636363636	0.00064098761412367	0.0312916972703772	1	1	0.973660185853867	0.999999950762617	0.289194115453516
up	TYROBP; CTLA4; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.00064995696816327	0.0548713671199383	1	1	0.999999999992456	0.999999999992456	0.453861970465408
down	WTIP; PDLIM1; PLOD2; PLAU; PLAT; CYP1A1; REG1A; TH; THBS1; SOD3; BMP2; PKM; ITGA2; ERCC2; EGR1; NF1; EDNRA; NOS1; NOS2; MMP14; TGFB2; CAV1; KCNMA1; POSTN; CYGB; AJUBA; ANGPTL4; NOX4; SLC2A8; LOXL2; MMP2; VEGFC;	GO:0001666~response to hypoxia	32	163	19.6319018404908	0.00072727641425018	0.0348251201997156	1	1	0.990361027641266	0.999999950762617	0.321849586639496
down	WNT9A; SNAI2; GLI2; PTHLH; CTNNB1; SOX9; NKX3-2; EFEMP1; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	9	20	45	0.00075486665786395	0.0355585155745019	1	1	0.995669121722551	0.999999950762617	0.328627538786239
down	CTNNB1; PLXNA3; PRKCZ; DDR1; POSTN; PAK6; FLRT3; EIF2AK4; PLXNA1;	GO:1990138~neuron projection extension	9	20	45	0.00075486665786395	0.0355585155745019	1	1	0.995669121722551	0.999999950762617	0.328627538786239
down	PTPRG; MCC; PBLD; PFN2; PTPRR; DAB2IP; PTPN23; DUSP10;	GO:0010633~negative regulation of epithelial cell migration	8	16	50	0.00087264553675847	0.0404488659198289	1	1	0.999999950762617	0.999999950762617	0.373823570505282
down	SOX18; BMPR2; PTPN14; CCBE1; PDPN; PROX1; FOXC2;	GO:0001946~lymphangiogenesis	7	12	58.3333333333333	0.00093590715270119	0.0420916556389776	1	1	0.999999950762617	0.999999950762617	0.389006036179813
down	NFIB; NRP1; EPHB2; RYK; GDNF; FZD3; SMO;	GO:0071679~commissural neuron axon guidance	7	12	58.3333333333333	0.00093590715270119	0.0420916556389776	1	1	0.999999950762617	0.999999950762617	0.389006036179813
down	NRP1; SEMA3F; PLXNA2; PLXNB1; PLXNA1; PLXNB3; PLXNA3;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	7	12	58.3333333333333	0.00093590715270119	0.0420916556389776	1	1	0.999999950762617	0.999999950762617	0.389006036179813
down	COL2A1; APP; PTHLH; EDN3; GNB3; TSPAN8; NF1; GDNF; LHX1; APBA1; PHLDA2; C9orf116; SHC4; MEGF8; TSKU; PROX1; FUT8; CRNN; POFUT2; MOK; ZNF827; ZFP64; TOB2; MAPK11; ZNF71; SHH; ZNF462; IHH; ZNF580; MAPK12; YBX2; MAPK4;	GO:0010468~regulation of gene expression	32	166	19.2771084337349	0.00094705375443737	0.0422094573323859	1	1	0.999999950762617	0.999999950762617	0.390094745310219
down	OBSL1; NEFL; PRKCZ; CRMP1; CUL7; TTBK2; CLASP1; MAP7D3; TTL; MAP6; MARK4; DOCK7; MARK1; SPATA7; CAMSAP3; TUBG2; TUBB6; CALML6; MAP1B; TUBB3; TUBG1; TUBAL3; CALML3; CALML5; TUBB;	GO:0000226~microtubule cytoskeleton organization	25	118	21.1864406779661	0.00105416734175301	0.0462715574099768	1	1	0.999999950762617	0.999999950762617	0.427636187331475
down	APOA1; APOE; APOC1; APOC3; LCAT; APOA4; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	8	17	47.0588235294118	0.00118218226432709	0.0503644414669939	1	1	0.999999950762617	0.999999950762617	0.465462131200725
down	LHX1; EFNB1; SIM2; IHH; SHH; PGAP1; SATB2; LRP6; RIPPLY3;	GO:0009880~embryonic pattern specification	9	22	40.9090909090909	0.00128710254236919	0.0525759770231292	1	1	0.999999950762617	0.999999950762617	0.485900877729057
down	AGRN; NRP1; RGS12; RGS5; ASAP2; PLXNB1; SIPA1L3; BCAR3; ARHGEF15; HRAS; JUN; ITGB1; ADCYAP1; NF1; CHML; CAV2; CCL11; S100A10; RIN1; DOCK1; RGN; ARHGAP29; ARHGAP21; DAB2IP; PREX2; RGPD4; ARHGAP22; NET1; SRGAP1; ELMOD1; SFRP1; TBC1D19; AGAP11; RGP1; DVL3; EVI5L; AGAP3; ACAP3; DLC1; RGPD5; CCL19; ARHGDIG; RTN4R; ARHGAP39; RASAL2; FZD10; STARD13; RAP1GDS1; CCL18; CX3CL1; CCL17; CCL14;	GO:0043547~positive regulation of GTPase activity	52	322	16.1490683229814	0.00131092154999668	0.0525759770231292	1	1	0.999999950762617	0.999999950762617	0.485900877729057
down	SLIT3; BMP2; TGFB2; MDM2; ACVR1; BMPR2; TBX5;	GO:0003181~atrioventricular valve morphogenesis	7	13	53.8461538461538	0.00132797294764386	0.0525759770231292	1	1	0.999999950762617	0.999999950762617	0.485900877729057
down	TBX3; EPHA2; MSX2; CCL11; DDR1; LRP5; LRP6;	GO:0060444~branching involved in mammary gland duct morphogenesis	7	13	53.8461538461538	0.00132797294764386	0.0525759770231292	1	1	0.999999950762617	0.999999950762617	0.485900877729057
down	WNT7A; CNTN5; WNT5A; EFNB2; WNT3A; NLGN4Y; NLGN2;	GO:0099054~presynapse assembly	7	13	53.8461538461538	0.00132797294764386	0.0525759770231292	1	1	0.999999950762617	0.999999950762617	0.485900877729057
down	ACVR1; HES1; TEAD2; MEGF8; MESP1; SOX17;	GO:0003143~embryonic heart tube morphogenesis	6	9	66.6666666666667	0.00133390897866759	0.0525759770231292	1	1	0.999999950762617	0.999999950762617	0.485900877729057
down	GATA4; NEDD4; FOXF1; BMPR2; TBX5; RBM24;	GO:0003197~endocardial cushion development	6	9	66.6666666666667	0.00133390897866759	0.0525759770231292	1	1	0.999999950762617	0.999999950762617	0.485900877729057
down	SMIM22; CXCL11; LAMA5; RBFOX2; NUAK1; PLAU; CXCL10; INHA; MELTF; NOS2; HOXD13; SOX9; JAG1; CXCL9; PKD2; BMPR2; SHH; PLCD3; NKX2-3; CIB1; ACE2; JAG2; FRK; JUN; TNK1; TGFB2; TFAP2B; GKN2; TFAP2A; BCL6B; GKN1;	GO:0042127~regulation of cell population proliferation	31	163	19.0184049079755	0.00135769791465379	0.0531520386317841	1	1	0.999999950762617	0.999999950762617	0.491224770067726
down	NRP1; SPRY2; SEMA7A; ABL1; HRAS; PDGFB; APOE; PDGFA; APP; JUN; SERPINF2; BMP2; MIF; ADCYAP1; FSHR; SHC1; S100A7; KDR; PLA2G5; GATA4; CX3CL1; PRKCZ; MAP3K12; GAS6; P2RY6; SYT14P1; FFAR4; CCL19; CIB1; NOX4; NDRG4; CCL11; CCL17; HMGB1P1; CCL14; ROR1; CCL18;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	37	209	17.7033492822967	0.0015550505265628	0.0584313207304908	1	1	0.999999950762617	0.999999950762617	0.540015262432944
down	BMP2; SOX9; ISL1; TGFB2; MDM2; ACVR1; TBX2; TWIST1;	GO:0003203~endocardial cushion morphogenesis	8	18	44.4444444444444	0.0015732285181147	0.0584313207304908	1	1	0.999999950762617	0.999999950762617	0.540015262432944
down	EFNA2; FUT1; LHX2; DLX2; EXT1; RPGRIP1L; CRTAC1; NR2E1;	GO:0021772~olfactory bulb development	8	18	44.4444444444444	0.0015732285181147	0.0584313207304908	1	1	0.999999950762617	0.999999950762617	0.540015262432944
down	NFIB; GLI2; EN2; BMP5; CTNNB1; HNF1B; SHH; GBX2;	GO:0030902~hindbrain development	8	18	44.4444444444444	0.0015732285181147	0.0584313207304908	1	1	0.999999950762617	0.999999950762617	0.540015262432944
down	BMP5; GJC1; CSRP3; TBX2; BMPR2; SGCG; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	8	18	44.4444444444444	0.0015732285181147	0.0584313207304908	1	1	0.999999950762617	0.999999950762617	0.540015262432944
down	TBX1; PLXNA2; BMP5; RIPPLY3; ISL1; ACVR1; SIX1; SIX4;	GO:0060037~pharyngeal system development	8	18	44.4444444444444	0.0015732285181147	0.0584313207304908	1	1	0.999999950762617	0.999999950762617	0.540015262432944
down	GLI3; CTNNB1; VEGFC; FOXG1; CX3CL1; SHH; DMRTA2; SMO; FZD3;	GO:0002052~positive regulation of neuroblast proliferation	9	23	39.1304347826087	0.0016483635545036	0.0596913652174615	1	1	0.999999950762617	0.999999950762617	0.55166044254871
down	PROM1; DSCAM; TSPAN12; TFAP2A; LHX1; SDK2; FJX1; TFAP2B; HIPK2;	GO:0010842~retina layer formation	9	23	39.1304347826087	0.0016483635545036	0.0596913652174615	1	1	0.999999950762617	0.999999950762617	0.55166044254871
down	DLL1; APOE; WNT5A; CD151; AP2B1; MIB1; NEDD4L; CCL19; MAPK8IP1;	GO:0045807~positive regulation of endocytosis	9	23	39.1304347826087	0.0016483635545036	0.0596913652174615	1	1	0.999999950762617	0.999999950762617	0.55166044254871
down	NRP1; TBX1; LDLR; APOE; NF1; HOXA1; HES1; FOXC2; STRA6;	GO:0048844~artery morphogenesis	9	23	39.1304347826087	0.0016483635545036	0.0596913652174615	1	1	0.999999950762617	0.999999950762617	0.55166044254871
up	FFAR3; NCR3; IL18RAP; LY86; CALCA; ORM1; FOLR2; AZU1; CRHBP; CD40LG; FCGR2B; CNR2; CXCR3; AIF1; NLRP6; MS4A2; FUT7; NAIP; NLRP9; IL27; PLD4; CD180; PROK2; TLR9; STAB1; PLA2G2D; PF4; PTGDR; CCL23; CCL24; PF4V1; CCR5; XCL1; CCR2; XCL2; IL2RA;	GO:0006954~inflammatory response	36	381	9.44881889763779	0.00166740721124059	0.135554030691596	1	1	0.999999999992456	0.999999999992456	1
down	TBX3; RBFOX2; PDGFB; CSF2; JUN; TFAP2A; GLI3; BMP2; WT1; NR2F2; SHC1; CTNNB1; MSX2; SOX18; WNT5A; HNF4A; ELK3; ID4; SOX9; LHX1; DAP; HMGA2; FOXG1; FOXL2; MDM2; FOXK2; MAP3K10; FOXF2; KLF10; TBX2; VGLL4; GAS6; HES1; PTPRK; NR0B2; TWIST1; FOXD1; ZNF423; ZNF318; DAB2IP; ERN2; SFRP1; DMBX1; TWIST2; TFAP2B; HDAC2; PROX1; JARID2; GATA6; SCMH1; HIC2; MESP1; ZKSCAN3; SOX7; LGR4; TP63; ZNF703; SMURF2; HMX1; UBP1; NDUFA13; DKK3; SIX4; YEATS2; LOXL2; MAGED1; NCOR2; PRDM8; SIX2; ZNF488; C11orf95; SIX5; DPF1; SIX1; ZFP90; ALX1; DPF3;	GO:0045892~negative regulation of transcription, DNA-templated	77	530	14.5283018867925	0.00169598202446253	0.0610342847809682	1	1	0.999999950762617	0.999999950762617	0.56407154418816
down	WNT7A; SOCS2; TBX3; SPRY2; DYRK3; BAG3; TFAP2A; KRT18; CEACAM5; FABP1; THBS1; IGF1R; ANXA4; GLI2; GLI3; MIF; NQO1; EPCAM; PRLR; WT1; SLC9A1; PAX7; EDNRB; SHC1; AQP1; CCND2; CTNNB1; MSX2; KDR; CDKN1A; GDNF; WNT5A; IER3; SOX9; HMGA2; NKX3-2; CX3CL1; PRKCZ; DHRS2; FHL2; GAS6; IHH; SHH; RGN; TWIST1; DDB1; FFAR4; SH3RF1; AMIGO2; ANKLE2; PDPN; SFRP1; IL31RA; OSR1; TWIST2; TFAP2B; HDAC2; KIFAP3; APBB2; GATA6; CIB1; SMO; FAIM2; ANGPTL4; SPHK1; BFAR; LHX3; SIX4; KLHL20; NR2E1; AXL; VIP;	GO:0043066~negative regulation of apoptotic process	72	489	14.7239263803681	0.00173065869194666	0.0616037638108476	1	1	0.999999950762617	0.999999950762617	0.569334601122793
down	APOA1; APOD; NEFL; TNC; MAP1B;	GO:0014012~peripheral nervous system axon regeneration	5	6	83.3333333333333	0.00175433569706418	0.0616037638108476	1	1	0.999999950762617	0.999999950762617	0.569334601122793
down	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00175433569706418	0.0616037638108476	1	1	0.999999950762617	0.999999950762617	0.569334601122793
down	WNT5A; RPGRIP1L; TP63; FZD3; CELSR1; VANGL2; PTK7;	GO:0001736~establishment of planar polarity	7	14	50	0.00183742747638937	0.0626817941904279	1	1	0.999999950762617	0.999999950762617	0.579297628674829
down	PIK3C2A; CD5L; LRP4; LRP5; ABL1; HRAS; LDLR; APP; GHR; APLP1; PRSS12; TMPRSS15; LGALS3BP; RIN1; SHH; SCARA3; ARC; EHBP1; STEAP2; DNER; SSC4D; SNX33; PGBD1; MTMR9; CD163L1; EHD2; SH3BP4; PACSIN3; LOXL2; LRP12; RAB34; MIB1;	GO:0006897~endocytosis	32	174	18.3908045977011	0.00183840371778721	0.0626817941904279	1	1	0.999999950762617	0.999999950762617	0.579297628674829
down	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22; CYP2U1;	GO:0097267~omega-hydroxylase P450 pathway	6	10	60	0.00197161549047997	0.0662249225663688	1	1	0.999999950762617	0.999999950762617	0.612042796434984
down	TBX1; GLI2; WNT5A; SOX9; HOXA1; PTK7; SIX1; MYO3A; VANGL2;	GO:0090103~cochlea morphogenesis	9	24	37.5	0.00208650153477408	0.0686885789345511	1	1	0.999999950762617	0.999999950762617	0.634811613288277
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00237169701896844	0.173039826213121	1	1	0.999999999992456	0.999999999992456	1
up	CALCA; OR56A1; GPR65; P2RY10; DRD3; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	8	39	20.5128205128205	0.00242886253951302	0.173039826213121	1	1	0.999999999992456	0.999999999992456	1
down	TH; FOXF2; TBX2; FZD5; IHH; HIPK2; LRP6;	GO:0048596~embryonic camera-type eye morphogenesis	7	15	46.6666666666667	0.00248617741143675	0.080027288454803	1	1	0.999999950762617	0.999999950762617	0.739602607581763
down	KCNK2; GJA1; VGLL4; MAPK11; JARID2; TBX5; SAV1;	GO:0060044~negative regulation of cardiac muscle cell proliferation	7	15	46.6666666666667	0.00248617741143675	0.080027288454803	1	1	0.999999950762617	0.999999950762617	0.739602607581763
up	LILRA5; IFNG; ORM1; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	6	22	27.2727272727273	0.00252264503710198	0.173039826213121	1	1	0.999999999992456	0.999999999992456	1
down	AGRN; SDC3; GPC4; SDC1; GPC1; HSPG2; HYAL2; HGSNAT; GPC6;	GO:0006027~glycosaminoglycan catabolic process	9	25	36	0.00261256150508038	0.0836308362455012	1	1	0.999999950762617	0.999999950762617	0.772906164331048
down	FOXN1; TBX1; COL4A1; SERPINF2; NR2F2; NEDD4; EFNB2; LAMA1;	GO:0048514~blood vessel morphogenesis	8	20	40	0.00265765779572347	0.0844457984361101	1	1	0.999999950762617	0.999999950762617	0.780437947212774
down	CXCL13; S100A8; THBS1; GJA1; CCL11;	GO:0002544~chronic inflammatory response	5	7	71.4285714285714	0.00278409458581952	0.0849002317380963	1	1	0.999999950762617	0.999999950762617	0.784637765319954
down	EFNA1; ACVR1; SOX4; BMPR2; TWIST1;	GO:0003183~mitral valve morphogenesis	5	7	71.4285714285714	0.00278409458581952	0.0849002317380963	1	1	0.999999950762617	0.999999950762617	0.784637765319954
down	HOXD10; ISL1; HOXC10; LHX3; MNX1;	GO:0021520~spinal cord motor neuron cell fate specification	5	7	71.4285714285714	0.00278409458581952	0.0849002317380963	1	1	0.999999950762617	0.999999950762617	0.784637765319954
down	NRP1; ABL1; APOA1; APOE; APOC3;	GO:0032489~regulation of Cdc42 protein signal transduction	5	7	71.4285714285714	0.00278409458581952	0.0849002317380963	1	1	0.999999950762617	0.999999950762617	0.784637765319954
down	NRP1; DSCAM; SEMA5A; BMPR2; MEGF8;	GO:0048842~positive regulation of axon extension involved in axon guidance	5	7	71.4285714285714	0.00278409458581952	0.0849002317380963	1	1	0.999999950762617	0.999999950762617	0.784637765319954
down	GLI3; HOXA1; BMPR2; SHH; LUZP1;	GO:0060840~artery development	5	7	71.4285714285714	0.00278409458581952	0.0849002317380963	1	1	0.999999950762617	0.999999950762617	0.784637765319954
down	AGR2; PTPN1; BAX; BAK1; DAB2IP;	GO:1903896~positive regulation of IRE1-mediated unfolded protein response	5	7	71.4285714285714	0.00278409458581952	0.0849002317380963	1	1	0.999999950762617	0.999999950762617	0.784637765319954
up	APOA2; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.00282279229057703	0.182236149347546	1	1	0.999999999992456	0.999999999992456	1
up	DBH; CRHBP; OPRM1; DRD3; OR56A1;	GO:0048149~behavioral response to ethanol	5	15	33.3333333333333	0.00282279229057703	0.182236149347546	1	1	0.999999999992456	0.999999999992456	1
down	APP; ITGA3; HNF1B; FOXL1; TMEM237; TCF7L1; DCDC2; VANGL2; DACT2;	GO:0030111~regulation of Wnt signaling pathway	9	26	34.6153846153846	0.00323829672499665	0.0964951323648542	1	1	0.999999950762617	0.999999950762617	0.891796447111914
down	SIPA1L3; FLNB; FAT1; IHH; RILPL1; DACT2; PALLD;	GO:0003382~epithelial cell morphogenesis	7	16	43.75	0.00329755543808097	0.0964951323648542	1	1	0.999999950762617	0.999999950762617	0.891796447111914
down	DRD1; MDK; EMX2; ATAT1; PROX1; SMO; NR2E1;	GO:0021542~dentate gyrus development	7	16	43.75	0.00329755543808097	0.0964951323648542	1	1	0.999999950762617	0.999999950762617	0.891796447111914
down	THBS1; GPC1; WNT5A; APLN; SPRY4; SPRY2; SHISA2;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	7	16	43.75	0.00329755543808097	0.0964951323648542	1	1	0.999999950762617	0.999999950762617	0.891796447111914
down	NRP1; ITGB1; KDR; EFNB2; EPHB4; CLEC14A; PIK3R3; ROBO1;	GO:0002042~cell migration involved in sprouting angiogenesis	8	21	38.0952380952381	0.00338253061015747	0.097991911776262	1	1	0.999999950762617	0.999999950762617	0.90562950302355
down	RYK; WNT5A; DVL3; FZD5; FZD3; FZD8; FZD10; SFRP1;	GO:0035567~non-canonical Wnt signaling pathway	8	21	38.0952380952381	0.00338253061015747	0.097991911776262	1	1	0.999999950762617	0.999999950762617	0.90562950302355
down	GLI2; GLI3; WNT5A; SHH;	GO:0007442~hindgut morphogenesis	4	4	100	0.00347790680291871	0.098779372627995	1	1	0.999999950762617	0.999999950762617	0.912907121827781
down	S100A8; ADH5; NOS1; NOS2;	GO:0018119~peptidyl-cysteine S-nitrosylation	4	4	100	0.00347790680291871	0.098779372627995	1	1	0.999999950762617	0.999999950762617	0.912907121827781
down	MESP1; GATA5; ROBO2; ROBO1;	GO:0035481~positive regulation of Notch signaling pathway involved in heart induction	4	4	100	0.00347790680291871	0.098779372627995	1	1	0.999999950762617	0.999999950762617	0.912907121827781
down	CXCL11; ADCY6; VIP; CXCL10; PTHLH; ADCYAP1; DRD1; ADORA2B; GPR3; CXCL9; ADCY2; ADCY1; ADM2; GPR161; UCN2; LGR4; PTGER1; FSHR; ADGRL4; ADGRL3; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	21	103	20.3883495145631	0.00374915653438057	0.104435639231736	1	1	0.999999950762617	0.999999950762617	0.965181659801998
down	TERT; TBX3; EPCAM; GJA1; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	6	12	50	0.00390247954035394	0.107671268841956	1	1	0.999999950762617	0.999999950762617	0.995084960827113
down	FN1; IVL; THBS1; FLG; SPRR1B; SPRR2E; SPRR1A; TGM3; TGM7;	GO:0018149~peptide cross-linking	9	27	33.3333333333333	0.00397610582516761	0.109182735312896	1	1	0.999999950762617	0.999999950762617	1
up	OXT; CRHBP; AVPR1A;	GO:0002125~maternal aggressive behavior	3	4	75	0.00399282774768661	0.236871808274922	1	1	0.999999999992456	0.999999999992456	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00399282774768661	0.236871808274922	1	1	0.999999999992456	0.999999999992456	1
up	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.00399282774768661	0.236871808274922	1	1	0.999999999992456	0.999999999992456	1
down	CTNNB1; WNT3; SFRP1; MDFI; VAX2;	GO:0009950~dorsal/ventral axis specification	5	8	62.5	0.00418904880533744	0.112367355454283	1	1	0.999999950762617	0.999999950762617	1
down	FOLR1; TGFB2; BMPR2; HES1; ADGRF5;	GO:0061626~pharyngeal arch artery morphogenesis	5	8	62.5	0.00418904880533744	0.112367355454283	1	1	0.999999950762617	0.999999950762617	1
down	WT1; PKD2; SIX1; OSR1; SIX4;	GO:0072075~metanephric mesenchyme development	5	8	62.5	0.00418904880533744	0.112367355454283	1	1	0.999999950762617	0.999999950762617	1
down	SH3PXD2B; CTNNB1; TGFB2; TP63; COLEC10;	GO:1904888~cranial skeletal system development	5	8	62.5	0.00418904880533744	0.112367355454283	1	1	0.999999950762617	0.999999950762617	1
down	TBX3; GLI2; ITGA2; HOXD9; SOX9; FASN; WNT3A; CAV1;	GO:0030879~mammary gland development	8	22	36.3636363636364	0.00425165708023256	0.113000463866365	1	1	0.999999950762617	0.999999950762617	1
down	ARHGAP42; ITGB1; ITGA3; TNFAIP1; KANK1; DLC1; HEG1; KCTD10;	GO:0035024~negative regulation of Rho protein signal transduction	8	22	36.3636363636364	0.00425165708023256	0.113000463866365	1	1	0.999999950762617	0.999999950762617	1
up	OR2A1; OR2T8; OR4E1; OR1D2; OR1D5; OR2B6; OR4D1; OR2B11; OR2G6; OR2T2; OR2W3; OR2L13; OR2C3; OR2L5; OR2AK2; OR2L3; OR10G2; OR56A1; OR52L2P; OR56B2P; OR52N4; OR56B1; OR5AN1; OR52B4; OR52K2; OR52K1; OR6K6; OR6K3; OR6N1; OR6N2; OR2L8; OR2T10; OR2T11; OR2T3; OR52P1P; OR5K1; OR5K2; OR2B2;	GO:0050911~detection of chemical stimulus involved in sensory perception of smell	38	435	8.73563218390805	0.00433306592227489	0.247847303286152	1	1	0.999999999992456	0.999999999992456	1
up	TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00440366506977674	0.247847303286152	1	1	0.999999999992456	0.999999999992456	1
down	GLI2; CTNNB1; TGFB2; TGM3; SHH; SOSTDC1; KRT27; SMO; TP63;	GO:0031069~hair follicle morphogenesis	9	28	32.1428571428571	0.00483895910848897	0.12744058670266	1	1	0.999999950762617	0.999999950762617	1
down	EPHB2; RYK; RPGRIP1L; RTN4RL1; LPAR1; RTN4R;	GO:0022038~corpus callosum development	6	13	46.1538461538462	0.00527166679619107	0.133965076390926	1	1	0.999999950762617	0.999999950762617	1
down	GATA4; ISL1; TGFB2; BMPR2; TBX5; SMO;	GO:0060413~atrial septum morphogenesis	6	13	46.1538461538462	0.00527166679619107	0.133965076390926	1	1	0.999999950762617	0.999999950762617	1
down	JUN; TFAP2A; INHBA; TWIST1; HDAC2; STRA6;	GO:0061029~eyelid development in camera-type eye	6	13	46.1538461538462	0.00527166679619107	0.133965076390926	1	1	0.999999950762617	0.999999950762617	1
down	FLRT2; COL4A1; ITGB1; CAV2; CAV1; FERMT1;	GO:0071711~basement membrane organization	6	13	46.1538461538462	0.00527166679619107	0.133965076390926	1	1	0.999999950762617	0.999999950762617	1
down	WNT5A; PTK7; SFRP1; CELSR1; VANGL2; DVL3;	GO:0090179~planar cell polarity pathway involved in neural tube closure	6	13	46.1538461538462	0.00527166679619107	0.133965076390926	1	1	0.999999950762617	0.999999950762617	1
up	SPI1; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	5	18	27.7777777777778	0.00539314845832739	0.295949021650716	1	1	0.999999999992456	0.999999999992456	1
down	SHOX2; GLI3; HNF1B; FOXF1; IHH; SHH; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	7	18	38.8888888888889	0.00550699543950706	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	GLI3; NF1; EPHB2; AQP5; SHROOM2; FAT1; TENM3;	GO:0048593~camera-type eye morphogenesis	7	18	38.8888888888889	0.00550699543950706	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	PLXNB1; FN1; TPM1; KDR; CCL11; FGD1; FAM171A1; CDC42EP5; FGD6; PDPN; BVES; FBLIM1; LPAR1; FERMT2; DLC1; S100A13; MYO10; PARVA; STRIP2; WASF3; FMNL2; PLXNB3; RHOC; PLXNA1; RHOBTB1; RAC3; PLXNA3; PLXNA2;	GO:0008360~regulation of cell shape	28	159	17.6100628930818	0.00570569062341886	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	GATA4; TGFB2; ACVR1; SOX4;	GO:0003289~atrial septum primum morphogenesis	4	5	80	0.00581332276152025	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	CHP2; BMP2; RGN; MTMR9;	GO:0010922~positive regulation of phosphatase activity	4	5	80	0.00581332276152025	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	APP; FOXG1; ROBO2; ROBO1;	GO:0016199~axon midline choice point recognition	4	5	80	0.00581332276152025	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	HMGB3; INHA; INHBA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	4	5	80	0.00581332276152025	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	HOXA3; NKX3-2; SHH; GATA6;	GO:0048645~animal organ formation	4	5	80	0.00581332276152025	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	LRP4; APP; SHANK2; SHANK3;	GO:0051124~synaptic growth at neuromuscular junction	4	5	80	0.00581332276152025	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	WNT9A; IHH; EXT1; OSR1;	GO:0072498~embryonic skeletal joint development	4	5	80	0.00581332276152025	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	RYK; WNT5A; FZD3; VANGL2;	GO:1904938~planar cell polarity pathway involved in axon guidance	4	5	80	0.00581332276152025	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	PLOD3; PLXNA2; NF1; EPHA2; PKD2; PROX1; SEMA3C; ZNF358; SALL2;	GO:0021915~neural tube development	9	29	31.0344827586207	0.00584031512919791	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	CYP1A1; APP; AQP1; MT2A; MT1B; MT1A; MT1M; MT1H; MT1E;	GO:0071280~cellular response to copper ion	9	29	31.0344827586207	0.00584031512919791	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	TMEM120B; KRBA1; OOEP; PCNX2; NCKAP5; FLRT2; HSPA12A; PLCH2; SORBS2; PRB2; MSMB; CRYBA2; DIO3; XG; RIPPLY3; FAM189B; WT1-AS; TCHH; KRTAP1-1; RAD51AP2; MN1; HMGXB3; TMEM132B; NOMO1; TMEM132A; KRT24; EXOC3L2; ACTBL2; C20orf194; ZNF697; HIST2H2AA3; C5orf46; C6orf15; IGFL3; PTCHD4; SLC46A3; KRT27; CTAGE6; KBTBD6; UNC93A; CPNE8; LIX1L; CTAGE4; CTAGE3P; SLC35F2; TMEM132C; ZNF114; FIBIN; NKX2-3; AGR3; GIPC2; CASKIN2; TMEM131; DCUN1D4; DPF3; ZBTB8A; KIF12; WBP1; CYYR1; MPP4; HIST1H2AH; DEPDC7; PMCHL2; TMEM121; FSD1L; GPR87; C22orf23; ZC3H12C; NRSN2; TMEM245; PLEKHA5; POPDC3; MAGEE1; INPP5E; CCM2L; ETNK2; TMEM51; CGN; STOML1; PSORS1C2; PCDHGB5; LINC01558;	GO:0008150~biological_process	82	603	13.5986733001658	0.00584585315576513	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	AKR1B15; PLOD2; MGST3; CYP27B1; AKR1B10; FADS1; PLOD3; FMO6P; CBR3; ALDH1L1; BBOX1; FADS2; CH25H; CYP1A1; LIPF; TH; GSTA1; SOD3; CYP2C9; BMP2; P4HA1; HSD17B1; NQO1; TYRP1; NOS1; FMO3; CYP2C19; NOS2; TDO2; FASN; ALDH7A1; DIO3; CYP4A11; AOX1; CYP24A1; CRYZ; DHRS2; PDIA5; CRYM; PTGR1; PDIA6; PTGIS; CYP27C1; CYP4A22; TXNDC8; NXN; ASPHD2; IYD; MICAL3; HSD11B1L; P3H3; MSRB3; CYP4X1; CYP4Z2P; SDR9C7; AKR7L; GPX8; PXDN; COX4I2; IL4I1; VAT1; NOX4; DUOX2; PNPO; CYP39A1; FADS3; CYP2U1; CYP2F1; CYP26A1; CYP2C18; CYP2S1; CYP51A1; STEAP2;	GO:0055114~oxidation-reduction process	73	526	13.8783269961977	0.00586105149771665	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	TNFRSF11B; CHEK1; TNFRSF10B; CD5L; CIDEA; TNFRSF21; UNC5C; PAK4; S100A8; S100A9; CEACAM5; LGALS1; CGB7; GJA1; ERCC2; PAX3; KRT20; IER3; LGALS7; DAP; APLP1; FAM3B; MAP3K10; BAX; IL24; BIK; TNFAIP1; DOCK1; GAS6; SIX1; BAK1; ECSCR; PHLDA2; SHC4; SH3RF1; PACS2; TNS4; DRAM1; SLC5A8; RNF152; PCSK9; PPP1R13L; PHLDA1; CSRNP3; TFAP2B; DPF1; ZDHHC16; CIDEC; IFI27L1; RNF183; DLC1; CIB1; RTKN; TRAF4; FAIM2; CADM1; BCL2L14; PEG3; CDIP1; TP63; SAV1; EVA1A; ZMAT3; TP53AIP1; TIGAR; PAK6; BFAR; PAK5; IL19; FBXO10; NISCH; HIF3A; KCNIP3; CASP14; CASP6; CASP12;	GO:0006915~apoptotic process	76	552	13.768115942029	0.005951179747272	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
up	IFNG; AZU1; AIF1; TLR8; TLR7; TREM2;	GO:0001774~microglial cell activation	6	27	22.2222222222222	0.00596460858398928	0.299814576884823	1	1	0.999999999992456	0.999999999992456	1
down	APOA1; APOE; APOC3; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.00603490444304378	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	FBN2; MFAP2; FOXL2; EFEMP1; VAX2;	GO:0048048~embryonic eye morphogenesis	5	9	55.5555555555556	0.00603490444304378	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	CTNNB1; GATA4; FOXF1; SHH; SOX17;	GO:0048617~embryonic foregut morphogenesis	5	9	55.5555555555556	0.00603490444304378	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	PLOD3; PXDN; LAMB3; NTN4; LAMB1;	GO:0070831~basement membrane assembly	5	9	55.5555555555556	0.00603490444304378	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
down	NEDD4; PCSK9; OSR1; NEDD4L; HECW1;	GO:2000650~negative regulation of sodium ion transmembrane transporter activity	5	9	55.5555555555556	0.00603490444304378	0.137515995038475	1	1	0.999999950762617	0.999999950762617	1
up	AVPR1A; AVPR1B; AVPR2;	GO:0001992~regulation of systemic arterial blood pressure by vasopressin	3	5	60	0.00614654030060002	0.299814576884823	1	1	0.999999999992456	0.999999999992456	1
up	FCGR2B; ZPBP2; FCRL3;	GO:0002638~negative regulation of immunoglobulin production	3	5	60	0.00614654030060002	0.299814576884823	1	1	0.999999999992456	0.999999999992456	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00614654030060002	0.299814576884823	1	1	0.999999999992456	0.999999999992456	1
up	TYROBP; DCSTAMP; TREM2;	GO:0034241~positive regulation of macrophage fusion	3	5	60	0.00614654030060002	0.299814576884823	1	1	0.999999999992456	0.999999999992456	1
down	SOCS2; MATN3; OBSL1; WFS1; PRSS23; FSTL3; APOA1; APOE; FN1; APP; LAMB1; MELTF; LGALS1; LAMC1; HRC; TNC; CHML; MFGE8; FSTL1; PSMD2; GAS6; CUL7; PDIA6; IGFBP7; DDB1; TMEM132A; NOTUM; FBXL19; AMTN; KBTBD6; FAM20C; FBXW8; PCSK9; FBXO22; FBXO30; ASB12; DDB2; SPSB1; FBXO17; DDA1; KLHL25; FBXO44; EVA1A; FBXL12; KLHL13; FBXL7; FBXO2; FBXO10; KLHL20; HIF3A; ASB1;	GO:0043687~post-translational protein modification	51	344	14.8255813953488	0.00654703230587783	0.147029089845954	1	1	0.999999950762617	0.999999950762617	1
down	CLCA1; S100A6; GJA1; ATP4A; ATP7B; GJC1; SCNN1G; CLCN2; FKBP1B; ASIC1; ATP2C1; GRIK2; FXYD3; ANO4; ANO1; ANO7; TMC7; SLC9B2; OSTM1; NALCN; UNC80; NEDD4L; TTYH3; ATP6V0A4; ATP13A2; ASIC5; SLC24A2; CLCA2; GABRB3; GABRD; GABRA4; HTR3B; HTR3A; GABRB2;	GO:0034220~ion transmembrane transport	34	208	16.3461538461538	0.00690028498662165	0.150510420253025	1	1	0.999999950762617	0.999999950762617	1
up	HBA1; HBG2; HBZ; HBD; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.00693507351875156	0.330923616818688	1	1	0.999999999992456	0.999999999992456	1
down	GLI2; MSX2; SHH; SATB2; TNN; PTHLH; LRP5;	GO:0002076~osteoblast development	7	19	36.8421052631579	0.00695627798946941	0.150510420253025	1	1	0.999999950762617	0.999999950762617	1
down	UNC13B; SERPINE2; GABRB3; NTF4; GABRB2; ISL1; SLITRK6;	GO:0060384~innervation	7	19	36.8421052631579	0.00695627798946941	0.150510420253025	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; ABL1; HRAS; CSF3; NTF3; BAIAP2L1; BAIAP2L2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	7	19	36.8421052631579	0.00695627798946941	0.150510420253025	1	1	0.999999950762617	0.999999950762617	1
down	SNAI2; EFNB2; SLURP1; PTPRK; CD109; KDF1;	GO:0010839~negative regulation of keratinocyte proliferation	6	14	42.8571428571429	0.00696182130269429	0.150510420253025	1	1	0.999999950762617	0.999999950762617	1
down	EXTL3; EXT1; EXT2; XYLT2; EXTL2; VANGL2;	GO:0015012~heparan sulfate proteoglycan biosynthetic process	6	14	42.8571428571429	0.00696182130269429	0.150510420253025	1	1	0.999999950762617	0.999999950762617	1
down	TBX1; FOXH1; JAG1; TBX2; SIX1; TFAP2B;	GO:0035909~aorta morphogenesis	6	14	42.8571428571429	0.00696182130269429	0.150510420253025	1	1	0.999999950762617	0.999999950762617	1
down	NF1; ITGA8; IHH; SHH; SMO; STRA6;	GO:0048745~smooth muscle tissue development	6	14	42.8571428571429	0.00696182130269429	0.150510420253025	1	1	0.999999950762617	0.999999950762617	1
down	TERT; PAK4; ABL1; SERPINE1; IL11; KDR; SEMA5A; GAS6; ANGPTL4;	GO:2000352~negative regulation of endothelial cell apoptotic process	9	30	30	0.00699402879879396	0.150644620298187	1	1	0.999999950762617	0.999999950762617	1
up	LTF; GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.00754737959414009	0.352478685300798	1	1	0.999999999992456	0.999999999992456	1
down	CLCA1; TERT; KCNK2; LMNA; FABP1; SLC9A1; AK4; AQP1; PCK1; STC1; GNGT1; MDM2; TWIST1; PTGIS; SFRP1; GATA6; COX4I2; SCN2A; HIPK2; TIGAR; HILPDA;	GO:0071456~cellular response to hypoxia	21	111	18.9189189189189	0.00779166009027632	0.164163194774767	1	1	0.999999950762617	0.999999950762617	1
down	CYP1A1; ADH1A; CYP2C9; UGT1A1; CYP2C19; AOX1; FMO2; UGT1A7;	GO:0017144~drug metabolic process	8	25	32	0.00790477895806185	0.165943077112356	1	1	0.999999950762617	0.999999950762617	1
down	MCF2L; SIPA1L3; TRIO; PLEKHG5; RHOBTB1; RHOC; VAV2; RAC3; FGD1; ITSN1; ARHGAP29; ARHGAP21; ARHGEF16; SYDE1; ARHGAP22; NET1; SRGAP1; NGEF; ARHGEF17; DLC1; DEPDC7; ARHGDIG; ARHGAP39; PLEKHG2; STARD13;	GO:0051056~regulation of small GTPase mediated signal transduction	25	141	17.7304964539007	0.00803076789033419	0.167979311034644	1	1	0.999999950762617	0.999999950762617	1
down	HOXC11; FGF1; HOXA11; GDNF; SIX1;	GO:0001759~organ induction	5	10	50	0.00838540217524775	0.168697986817311	1	1	0.999999950762617	0.999999950762617	1
down	REG1A; CPS1; WNT5A; FOXF1; SMO;	GO:0007494~midgut development	5	10	50	0.00838540217524775	0.168697986817311	1	1	0.999999950762617	0.999999950762617	1
down	PAX7; WNT3A; SHH; TCTN1; SMO;	GO:0021904~dorsal/ventral neural tube patterning	5	10	50	0.00838540217524775	0.168697986817311	1	1	0.999999950762617	0.999999950762617	1
down	MMP14; MMP16; STC1; HMGA2; IHH;	GO:0035988~chondrocyte proliferation	5	10	50	0.00838540217524775	0.168697986817311	1	1	0.999999950762617	0.999999950762617	1
down	BMP5; DDR1; TCF15; SHROOM2; STRA6;	GO:0043583~ear development	5	10	50	0.00838540217524775	0.168697986817311	1	1	0.999999950762617	0.999999950762617	1
down	AXL; WNT5A; LHX1; BAX; BAK1;	GO:0060068~vagina development	5	10	50	0.00838540217524775	0.168697986817311	1	1	0.999999950762617	0.999999950762617	1
down	HOXC11; SHOX2; COL2A1; HOXA11; OSR1;	GO:0060272~embryonic skeletal joint morphogenesis	5	10	50	0.00838540217524775	0.168697986817311	1	1	0.999999950762617	0.999999950762617	1
down	LRP4; EPHB2; NLGN2; NLGN4Y; CEL;	GO:0097104~postsynaptic membrane assembly	5	10	50	0.00838540217524775	0.168697986817311	1	1	0.999999950762617	0.999999950762617	1
down	EPCAM; TRIM32; TWIST1; DUOXA2; CCL19; DUOX2; PHPT1;	GO:2000147~positive regulation of cell motility	7	20	35	0.00866998684160847	0.173819736194739	1	1	0.999999950762617	0.999999950762617	1
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00887154826448677	0.384053045377136	1	1	0.999999999992456	0.999999999992456	1
up	APOA2; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.00887154826448677	0.384053045377136	1	1	0.999999999992456	0.999999999992456	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00887154826448677	0.384053045377136	1	1	0.999999999992456	0.999999999992456	1
down	SERPINE1; SERPINE2; THBS1; SERPINF2;	GO:0010757~negative regulation of plasminogen activation	4	6	66.6666666666667	0.00899961529479176	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	SERPINB7; THBS1; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	4	6	66.6666666666667	0.00899961529479176	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	JAG1; MCOLN3; USH1C; PDZD7;	GO:0042491~inner ear auditory receptor cell differentiation	4	6	66.6666666666667	0.00899961529479176	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	EFNB2; CCBE1; PROX1; HEG1;	GO:0048845~venous blood vessel morphogenesis	4	6	66.6666666666667	0.00899961529479176	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	GATA4; TGFB2; GATA6; TBX5;	GO:0051891~positive regulation of cardioblast differentiation	4	6	66.6666666666667	0.00899961529479176	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	SOX9; LHX1; EMX2; LZTS2;	GO:0072197~ureter morphogenesis	4	6	66.6666666666667	0.00899961529479176	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	MYO1C; ADAMTS3; CCBE1; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	4	6	66.6666666666667	0.00899961529479176	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	LRP6; RYK; WNT5A; WNT3A;	GO:1904953~Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	4	6	66.6666666666667	0.00899961529479176	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	CTNNB1; SOX18; TBX2; FOXC2; SOX17; NDRG4;	GO:0035050~embryonic heart tube development	6	15	40	0.00901157883325976	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	GFRA3; NF1; GDNF; SOX4; TFAP2B; TP63;	GO:0048485~sympathetic nervous system development	6	15	40	0.00901157883325976	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
down	HOXA5; LAMA1; CTNNB1; SOX9; FOXF1; DLG5;	GO:0060441~epithelial tube branching involved in lung morphogenesis	6	15	40	0.00901157883325976	0.174043625866357	1	1	0.999999950762617	0.999999950762617	1
up	DBH; HRH2; GJA5; AVPR1B; AVPR2; AVPR1A;	GO:0045907~positive regulation of vasoconstriction	6	30	20	0.00921020217712132	0.388776803438102	1	1	0.999999999992456	0.999999999992456	1
down	SNAI2; SHOX2; SEMA7A; BMP2; NF1; TNC; EPHA2; MSX2; ID4; FASN; DLX5; WNT3A; CYP24A1; FHL2; IHH; TWIST1; SND1; SFRP1; SMO; LGR4;	GO:0001649~osteoblast differentiation	20	106	18.8679245283019	0.00947502624657282	0.179994433025059	1	1	0.999999950762617	0.999999950762617	1
down	SNAI2; ATRN; TH; NF1; KRT76; EN1; VANGL1; TYRP1;	GO:0043473~pigmentation	8	26	30.7692307692308	0.0095331535590083	0.180506835689196	1	1	0.999999950762617	0.999999950762617	1
down	HOXA3; AXL; JAG1; MDM2; BAX; BMPR2; BAK1; FOXC2; SEMA3C;	GO:0001974~blood vessel remodeling	9	32	28.125	0.00981533082023789	0.183451699265995	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; THBS1; CDH13; CCBE1; E2F7; PARVA; LOXL2; KDR; VEGFC;	GO:0002040~sprouting angiogenesis	9	32	28.125	0.00981533082023789	0.183451699265995	1	1	0.999999950762617	0.999999950762617	1
down	DLL1; SOX12; BAG3; NEFL; ERCC2; NF1; SOX4; PKD2; ROBO2;	GO:0021510~spinal cord development	9	32	28.125	0.00981533082023789	0.183451699265995	1	1	0.999999950762617	0.999999950762617	1
down	CXCL13; TSPAN12; EFNA1; NF1; EPHA2; CTNNB1; SFRP1; TNFRSF12A; PROK1;	GO:0045765~regulation of angiogenesis	9	32	28.125	0.00981533082023789	0.183451699265995	1	1	0.999999950762617	0.999999950762617	1
up	AVPR1A; AVPR1B; NTRK2; P2RY12; NMUR1; GPR55;	GO:0007202~activation of phospholipase C activity	6	31	19.3548387096774	0.0105275702475222	0.427926235061317	1	1	0.999999999992456	0.999999999992456	1
down	FMO2; CYP2F1; CYP2U1; CYP2C19; CYP2S1; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	7	21	33.3333333333333	0.010674096523653	0.195096893558504	1	1	0.999999950762617	0.999999950762617	1
down	CLDN14; CLDN8; CLDN12; CLDN17; CLDN18; CLDN2; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	7	21	33.3333333333333	0.010674096523653	0.195096893558504	1	1	0.999999950762617	0.999999950762617	1
down	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP2S1; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	7	21	33.3333333333333	0.010674096523653	0.195096893558504	1	1	0.999999950762617	0.999999950762617	1
down	FSTL3; APOA1; WT1; NF1; MDK; STRA6; DKK3;	GO:0030325~adrenal gland development	7	21	33.3333333333333	0.010674096523653	0.195096893558504	1	1	0.999999950762617	0.999999950762617	1
down	KLK8; TUBB; ETV5; WNT5A; WNT3A; IGSF9; NEDD4;	GO:0050807~regulation of synapse organization	7	21	33.3333333333333	0.010674096523653	0.195096893558504	1	1	0.999999950762617	0.999999950762617	1
down	ITGB1; BMP2; SLC9A1; GATA6; TBX5; MESP1; NOX4;	GO:0055007~cardiac muscle cell differentiation	7	21	33.3333333333333	0.010674096523653	0.195096893558504	1	1	0.999999950762617	0.999999950762617	1
down	LMX1B; LRP6; EN1; SHH; SFRP1; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	7	21	33.3333333333333	0.010674096523653	0.195096893558504	1	1	0.999999950762617	0.999999950762617	1
down	LAMA5; TGFB1I1; VEGFC; KDF1; JAG2;	GO:0016331~morphogenesis of embryonic epithelium	5	11	45.4545454545455	0.0113007597592115	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	COL4A1; COL4A5; DDR1; COL4A6; COL4A2;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	5	11	45.4545454545455	0.0113007597592115	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	SERPINF2; WNT5A; WNT3A; PTPRU; FOXA2;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	5	11	45.4545454545455	0.0113007597592115	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	GFRA3; NF1; EDNRB; UGT8; NTF3; ARTN; NTF4; GDNF;	GO:0007422~peripheral nervous system development	8	27	29.6296296296296	0.0113982963246162	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; APOE; APOC3; HNF4A; GCKR; GPIHBP1; ANGPTL4; APOA4;	GO:0070328~triglyceride homeostasis	8	27	29.6296296296296	0.0113982963246162	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	MT1E; MT1B; MT2A; MT1A; MT1H; MT1M;	GO:0010273~detoxification of copper ion	6	16	37.5	0.0114586043663872	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	PLCH1; PLCD4; PLCZ1; PLCB4; PLCD3; PLCH2;	GO:0032959~inositol trisphosphate biosynthetic process	6	16	37.5	0.0114586043663872	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	EDN3; EDN2; EDNRB; EDNRA; HTR7; CAV1;	GO:0042310~vasoconstriction	6	16	37.5	0.0114586043663872	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	GLI2; GLI3; TGFB2; FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	6	16	37.5	0.0114586043663872	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	SOCS2; AREG; PRLR; HOXA5; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	6	16	37.5	0.0114586043663872	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	GATA4; AP2B1; MDM2; PTK7; HES1; LUZP1; TBX5; STRA6; HEG1;	GO:0003281~ventricular septum development	9	33	27.2727272727273	0.0115116928474545	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	LDLR; APOE; NTF4; PRKCZ; ADCY1; NFATC4; ARC; PTCHD1; EIF2AK4;	GO:0007616~long-term memory	9	33	27.2727272727273	0.0115116928474545	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	LAMB1; INHBA; SDC1; AQP1; AQP5; TGFB2; TWIST1; OSR1; TUFT1;	GO:0042476~odontogenesis	9	33	27.2727272727273	0.0115116928474545	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
down	DLL1; NOS1; CTNNB1; WNT3; CX3CL1; DOCK7; HES7; HES1; HES2;	GO:0050767~regulation of neurogenesis	9	33	27.2727272727273	0.0115116928474545	0.19969685137171	1	1	0.999999950762617	0.999999950762617	1
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.011697565787411	0.450458893041528	1	1	0.999999999992456	0.999999999992456	1
up	IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	4	14	28.5714285714286	0.011697565787411	0.450458893041528	1	1	0.999999999992456	0.999999999992456	1
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	APP; TUBB; MAP1B;	GO:0009987~cellular process	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	MDK; TTBK2; FAIM2;	GO:0021681~cerebellar granular layer development	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	FOXH1; BMP2; GATA4;	GO:0035054~embryonic heart tube anterior/posterior pattern specification	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	GLI3; IHH; SHH;	GO:0046639~negative regulation of alpha-beta T cell differentiation	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; CTNNB1; LHX1;	GO:0060066~oviduct development	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	SPDEF; AGR2; HOXA5;	GO:0060480~lung goblet cell differentiation	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	ISL1; MESP1; SOX17;	GO:0060913~cardiac cell fate determination	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	TBX3; WT1; ACVR1;	GO:0060923~cardiac muscle cell fate commitment	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
down	HNF1B; SIX1; SIX4;	GO:0072095~regulation of branch elongation involved in ureteric bud branching	3	3	100	0.0120109334659022	0.200968587249729	1	1	0.999999950762617	0.999999950762617	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.0121962537452989	0.450462343249824	1	1	0.999999999992456	0.999999999992456	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0121962537452989	0.450462343249824	1	1	0.999999999992456	0.999999999992456	1
down	ITGB1; ITGAV; ITGA2; ITGB6; COL16A1; ITGBL1; ITGB4;	GO:0033627~cell adhesion mediated by integrin	7	22	31.8181818181818	0.0129941402234125	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	KRT18; KRT16; KRT6C; DST; FAM83H; EVPLL; PLEC;	GO:0045104~intermediate filament cytoskeleton organization	7	22	31.8181818181818	0.0129941402234125	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	RASSF10; MDK; LHX2; WNT3A; PROX1; DISP3; NR2E1;	GO:2000179~positive regulation of neural precursor cell proliferation	7	22	31.8181818181818	0.0129941402234125	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; COBL; CTNNB1; FZD5;	GO:0000578~embryonic axis specification	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	DDAH1; FAH; NOS1; NOS2;	GO:0006527~arginine catabolic process	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	APP; TH; DRD1; NHLH2;	GO:0007617~mating behavior	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	TBX3; HOXD8; WNT5A; FZD5;	GO:0008595~anterior/posterior axis specification, embryo	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	LHX1; PROX1; HIPK2; LRP6;	GO:0060059~embryonic retina morphogenesis in camera-type eye	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	PROM1; WT1; FOXC2; KLF15;	GO:0072112~glomerular visceral epithelial cell differentiation	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	BCAR3; EDNRB; EDNRA; BCAR1;	GO:0086100~endothelin receptor signaling pathway	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	WNT9B; LRP6; RYK; CTNNB1;	GO:1904948~midbrain dopaminergic neuron differentiation	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	JUN; FOSL1; CTNNB1; TWIST1;	GO:2000144~positive regulation of DNA-templated transcription, initiation	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	LHX1; TENM4; OSR1; FOXA2;	GO:2000543~positive regulation of gastrulation	4	7	57.1428571428571	0.0131397750649088	0.207443751297225	1	1	0.999999950762617	0.999999950762617	1
down	SHANK2; SHANK3; ADRA1D; DRD1; ADRA1B; ADRA2B; PMCHL2; ADRA2C;	GO:0007610~behavior	8	28	28.5714285714286	0.013518922181624	0.211128396550753	1	1	0.999999950762617	0.999999950762617	1
down	CTNNB1; LHX1; ACVR1; TENM4; LRP5; LRP6;	GO:0001702~gastrulation with mouth forming second	6	17	35.2941176470588	0.01433897457637	0.218631628146021	1	1	0.999999950762617	0.999999950762617	1
down	KRT16; CA9; FREM2; FRAS1; TBX5; SOX9;	GO:0002009~morphogenesis of an epithelium	6	17	35.2941176470588	0.01433897457637	0.218631628146021	1	1	0.999999950762617	0.999999950762617	1
down	CABYR; NME5; SPA17; CCDC40; DNAH5; SPAG17;	GO:0003351~epithelial cilium movement involved in extracellular fluid movement	6	17	35.2941176470588	0.01433897457637	0.218631628146021	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; APOE; APOC3; LCAT; APOA4; LIPG;	GO:0043691~reverse cholesterol transport	6	17	35.2941176470588	0.01433897457637	0.218631628146021	1	1	0.999999950762617	0.999999950762617	1
down	LAMA1; WNT5A; TCF15; FOXF1; PTK7; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	6	17	35.2941176470588	0.01433897457637	0.218631628146021	1	1	0.999999950762617	0.999999950762617	1
down	EFNA2; GJA1; EPHA2; LGR4; LRP5; LRP6;	GO:0046849~bone remodeling	6	17	35.2941176470588	0.01433897457637	0.218631628146021	1	1	0.999999950762617	0.999999950762617	1
down	HES1; FAT4; IFT27; VANGL2; USH1C; IFT88;	GO:0060122~inner ear receptor cell stereocilium organization	6	17	35.2941176470588	0.01433897457637	0.218631628146021	1	1	0.999999950762617	0.999999950762617	1
down	BMP2; BMP1; MDK; WNT5A; SOX9; BMPR2;	GO:0061036~positive regulation of cartilage development	6	17	35.2941176470588	0.01433897457637	0.218631628146021	1	1	0.999999950762617	0.999999950762617	1
up	CALCA; FOLR2; CCR2; CCL23; XCL2; CCL24; XCL1;	GO:0002548~monocyte chemotaxis	7	44	15.9090909090909	0.014558067690831	0.450462343249824	1	1	0.999999999992456	0.999999999992456	1
up	PF4; IRF8; IRF4; BATF; GBP7;	GO:0042832~defense response to protozoan	5	24	20.8333333333333	0.0147759857466913	0.450462343249824	1	1	0.999999999992456	0.999999999992456	1
down	DLL1; BMP5; WNT5A; HNF4A; SMO;	GO:0003323~type B pancreatic cell development	5	12	41.6666666666667	0.0148363615067788	0.220415073257119	1	1	0.999999950762617	0.999999950762617	1
down	ADH1B; ADH1C; ADH1A; ADH5; ALDH1B1;	GO:0006069~ethanol oxidation	5	12	41.6666666666667	0.0148363615067788	0.220415073257119	1	1	0.999999950762617	0.999999950762617	1
down	GBX2; SHH; PTCHD1; SMO; LRP6;	GO:0021794~thalamus development	5	12	41.6666666666667	0.0148363615067788	0.220415073257119	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; APOE; APOC1; APOC3; APOA4;	GO:0033700~phospholipid efflux	5	12	41.6666666666667	0.0148363615067788	0.220415073257119	1	1	0.999999950762617	0.999999950762617	1
down	PLA2R1; HIC1; SPRED2; SPRED1; SPRED3;	GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator	5	12	41.6666666666667	0.0148363615067788	0.220415073257119	1	1	0.999999950762617	0.999999950762617	1
down	BMP2; WNT5A; TGFB2; BMPR2; TOB2;	GO:0045778~positive regulation of ossification	5	12	41.6666666666667	0.0148363615067788	0.220415073257119	1	1	0.999999950762617	0.999999950762617	1
down	SLITRK5; ABL1; HSPG2; NXN; SPEG;	GO:0072358~cardiovascular system development	5	12	41.6666666666667	0.0148363615067788	0.220415073257119	1	1	0.999999950762617	0.999999950762617	1
down	PLXNB1; GABRB3; WNT5A; GABRB2; NLGN2;	GO:1904862~inhibitory synapse assembly	5	12	41.6666666666667	0.0148363615067788	0.220415073257119	1	1	0.999999950762617	0.999999950762617	1
down	TERT; PDGFB; JUN; BMP2; EGR1; WT1; TGFB2; APLN; SREBF2;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	9	35	25.7142857142857	0.0155477308635326	0.229804981181907	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; APP; CBLN1; WNT3A; LRFN4; LRFN3; GPC6; GPC4;	GO:1905606~regulation of presynapse assembly	8	29	27.5862068965517	0.0159133947534033	0.234015759393955	1	1	0.999999950762617	0.999999950762617	1
up	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0161399527477678	0.472362617084671	1	1	0.999999999992456	0.999999999992456	1
up	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.0161399527477678	0.472362617084671	1	1	0.999999999992456	0.999999999992456	1
up	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0161399527477678	0.472362617084671	1	1	0.999999999992456	0.999999999992456	1
up	CD40LG; XCL1; TIGIT; TLR9; TREM2;	GO:0032733~positive regulation of interleukin-10 production	5	25	20	0.0170024688851715	0.488506699394015	1	1	0.999999999992456	0.999999999992456	1
up	LILRA5; ORM1; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	6	35	17.1428571428571	0.0171366814821591	0.488506699394015	1	1	0.999999999992456	0.999999999992456	1
down	UNC13B; MCF2L; TRIO; PLEKHG5; UNC5C; SPDEF; BCL10; ABL1; JUN; ITGB1; BMP2; FOSL1; SLC9A1; HOXA5; NF1; CTNNB1; VAV2; HMGA2; FOXL2; FGD1; SOX4; BAX; KCNMA1; MLLT11; ITSN1; BAK1; PHLDA2; PIP5KL1; STPG1; ARHGEF16; DAB2IP; NET1; SFRP1; NGEF; CSRNP3; LPAR1; APBB2; ARHGEF17; SAV1; PLEKHG2; ZMAT3; TNFRSF12A; NOX4; MAP3K10; SPANXA2-OT1; TNFRSF10B; PHLDA1;	GO:0043065~positive regulation of apoptotic process	47	332	14.1566265060241	0.0173119311660904	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	CTSE; IHH; SHH; PCSK9; KLK6; MYRF;	GO:0016540~protein autoprocessing	6	18	33.3333333333333	0.0176866168517145	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; SEMA4F; EPHB2; ISL1; NRCAM; ROBO2;	GO:0031290~retinal ganglion cell axon guidance	6	18	33.3333333333333	0.0176866168517145	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	MT2A; MT1A; MT1E; MT1B; MT1H; MT1M;	GO:0045926~negative regulation of growth	6	18	33.3333333333333	0.0176866168517145	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; EPHB2; ARC; SHANK3; CTNND2; SHANK2;	GO:0060997~dendritic spine morphogenesis	6	18	33.3333333333333	0.0176866168517145	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
up	CYP11B1; AIF1; PROKR2; AVPR2; GPR150; AVPR1B; AVPR1A;	GO:0032870~cellular response to hormone stimulus	7	46	15.2173913043478	0.0177558337232654	0.499667372084199	1	1	0.999999999992456	0.999999999992456	1
down	TERT; BMP2; WNT3; KANK1; SHH; DIXDC1; RSPO1; SFRP1; SPIN1;	GO:0030177~positive regulation of Wnt signaling pathway	9	36	25	0.0179156743350199	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	TNFRSF21; BCL10; BAX; BAK1;	GO:0001783~B cell apoptotic process	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	PDGFB; APOE; PDGFA; C1QTNF1;	GO:0010544~negative regulation of platelet activation	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	GJB1; GJA1; GJB2; GJC1;	GO:0016264~gap junction assembly	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	PDLIM1; SLC9A1; DST; DLG5;	GO:0030011~maintenance of cell polarity	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	CFTR; AQP1; SCNN1G; AQP4;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	DLL1; PROM1; LRP5; PROX1;	GO:0060042~retina morphogenesis in camera-type eye	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	MMP2; MSX2; FBN2; SFRP1;	GO:0060346~bone trabecula formation	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	ABL1; SOX4; TMEM231; B9D1;	GO:0060563~neuroepithelial cell differentiation	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	DLL1; ITGA3; JAG1; SIX2;	GO:0072006~nephron development	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	MELTF; FSCN1; CLASP1; PDPN;	GO:0090091~positive regulation of extracellular matrix disassembly	4	8	50	0.0183176153044531	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	LRP5; TFAP2A; PAX1; MMP13; SP5; HAS2; PAPPA2; LRP6;	GO:0060349~bone morphogenesis	8	30	26.6666666666667	0.0185995493199731	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	EFNA1; BMP5; PBLD; DAB2IP; SFRP1; TBX5; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	7	24	29.1666666666667	0.0186800887270433	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	MGST3; CIDEA; RDH16; CH25H; LDLR; APOC1; APOD; RBP3; PC; UGT2B7; CEL; NR2F2; HNF4A; PNLIPRP1; PLTP; PAFAH1B2; HSPG2; SREBF2; PAFAH1B3; ANGPTL4; LIPG; HMGCLL1;	GO:0006629~lipid metabolic process	22	130	16.9230769230769	0.0189011953299305	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
up	LTF; MS4A1; CCR2; CCR6; TREM2; JCHAIN; IFNG; AIRE;	GO:0006959~humoral immune response	8	58	13.7931034482759	0.018947960507961	0.526465484999676	1	1	0.999999999992456	0.999999999992456	1
down	KRT6B; STX2; CTNNB1; SHH; VAX2;	GO:0007398~ectoderm development	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	AREG; MDK; CDH3; HAS2; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	FN1; APP; MAPK12; CAV1; NDUFA13;	GO:0010952~positive regulation of peptidase activity	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	PAX7; LHX1; WNT3A; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; APOE; BMP1; ZDHHC8; APOA4;	GO:0034380~high-density lipoprotein particle assembly	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	CTNNB1; ACVR1; FOXF1; NFATC4; GATA6;	GO:0051145~smooth muscle cell differentiation	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	EDNRA; LHX1; MMP14; STRA6; FLRT3;	GO:0060322~head development	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	PRLR; HOXA5; SMO; ZNF703; ELF5;	GO:0060644~mammary gland epithelial cell differentiation	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	SIPA1L3; HES1; CLASP1; FERMT1; FRMD4A;	GO:0090162~establishment of epithelial cell polarity	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	TERT; CHEK1; SERPINE1; CDKN1A; PLA2R1;	GO:0090399~replicative senescence	5	13	38.4615384615385	0.0190417007246462	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
up	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.0194403633521268	0.53339496947398	1	1	0.999999999992456	0.999999999992456	1
down	PLK5; RBMS3; CASC2;	GO:0002357~defense response to tumor cell	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	PDGFB; GJA1; GAS6;	GO:0003104~positive regulation of glomerular filtration	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	CTNNB1; ISL1; HES1;	GO:0003266~regulation of secondary heart field cardioblast proliferation	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	TGFB2; ACVR1; GATA5;	GO:0003274~endocardial cushion fusion	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	CTNNB1; WNT7B; FRAS1;	GO:0003338~metanephros morphogenesis	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	FN1; ITGB1; VWA2;	GO:0007161~calcium-independent cell-matrix adhesion	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	SOX1; DMRT3; LHX3;	GO:0021521~ventral spinal cord interneuron specification	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	LHX1; WNT7B; PGAP1;	GO:0021871~forebrain regionalization	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	GLI2; SHH; SMO;	GO:0021938~smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; CTNNB1; WNT7B;	GO:0022009~central nervous system vasculogenesis	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	BMP2; BMP5; DKK3;	GO:0032348~negative regulation of aldosterone biosynthetic process	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	TGFB2; SOX4; HES1;	GO:0035910~ascending aorta morphogenesis	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	HOXA5; JAG1; CSF3;	GO:0045639~positive regulation of myeloid cell differentiation	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	SCN2B; TH; DDC;	GO:0046684~response to pyrethroid	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	EPHB2; APLNR; HEG1;	GO:0050878~regulation of body fluid levels	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	SOX18; PROX1; SOX17;	GO:0060214~endocardium formation	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	PROM1; DSCAM; SDK2;	GO:0060219~camera-type eye photoreceptor cell differentiation	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	HOXA5; WNT7B; LRP6;	GO:0060535~trachea cartilage morphogenesis	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	GDNF; SIX1; SIX4;	GO:0072107~positive regulation of ureteric bud formation	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	SPRED2; SPRED1; SPRED3;	GO:0090311~regulation of protein deacetylation	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	APP; ITGB1; SLC12A2;	GO:0150003~regulation of spontaneous synaptic transmission	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	PTPRG; PTPRR; TENM3;	GO:1903385~regulation of homophilic cell adhesion	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	BMP2; BMP5; DKK3;	GO:2000065~negative regulation of cortisol biosynthetic process	3	4	75	0.0196142828273855	0.250872306185147	1	1	0.999999950762617	0.999999950762617	1
down	EPCAM; SDC1; WT1; LHX1; SIX1; SFRP1; OSR1; FOXC2; ROBO2;	GO:0001657~ureteric bud development	9	37	24.3243243243243	0.0205352127190529	0.259783891908717	1	1	0.999999950762617	0.999999950762617	1
down	POU2F2; AXL; CTNNB1; SOX18; FZD5; HES1; IHH; CCL19; LHX6;	GO:0048469~cell maturation	9	37	24.3243243243243	0.0205352127190529	0.259783891908717	1	1	0.999999950762617	0.999999950762617	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0207139314567262	0.547796139126674	1	1	0.999999999992456	0.999999999992456	1
up	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0207139314567262	0.547796139126674	1	1	0.999999999992456	0.999999999992456	1
up	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0207139314567262	0.547796139126674	1	1	0.999999999992456	0.999999999992456	1
down	DDAH1; APOE; MT1M; MAFA; NOS1; NOS2;	GO:0007263~nitric oxide mediated signal transduction	6	19	31.5789473684211	0.0215328130871957	0.268494983992657	1	1	0.999999950762617	0.999999950762617	1
down	LRP4; MDK; SOX9; SFRP1; KREMEN2; SOST;	GO:0030279~negative regulation of ossification	6	19	31.5789473684211	0.0215328130871957	0.268494983992657	1	1	0.999999950762617	0.999999950762617	1
down	LDLR; APOA1; LCAT; CFTR; CAV1; NPC1L1;	GO:0030301~cholesterol transport	6	19	31.5789473684211	0.0215328130871957	0.268494983992657	1	1	0.999999950762617	0.999999950762617	1
down	SORBS3; ITGB1; ITGAV; ITGA2; GAS6; FAT2;	GO:0031589~cell-substrate adhesion	6	19	31.5789473684211	0.0215328130871957	0.268494983992657	1	1	0.999999950762617	0.999999950762617	1
down	APOC1; APOC3; PCSK9; NPC1L1; APOA4; APOA1;	GO:0042157~lipoprotein metabolic process	6	19	31.5789473684211	0.0215328130871957	0.268494983992657	1	1	0.999999950762617	0.999999950762617	1
down	PLOD3; APOE; DRD1; EDNRB; NOS1; CPS1;	GO:0042311~vasodilation	6	19	31.5789473684211	0.0215328130871957	0.268494983992657	1	1	0.999999950762617	0.999999950762617	1
down	APOE; THBS1; GJA1; NF1; NR2F2; CAV2; CAV1; TNMD;	GO:0001937~negative regulation of endothelial cell proliferation	8	31	25.8064516129032	0.0215945223577111	0.268494983992657	1	1	0.999999950762617	0.999999950762617	1
down	HOXC6; PAX7; WNT5A; DLX1; NKX3-2; HOXC5; SHH; KIAA1217;	GO:0048706~embryonic skeletal system development	8	31	25.8064516129032	0.0215945223577111	0.268494983992657	1	1	0.999999950762617	0.999999950762617	1
down	SERPINB7; SERPINF2; ITGA2; IHH; HDAC2; LARP6; SUCO;	GO:0032967~positive regulation of collagen biosynthetic process	7	25	28	0.022092113081412	0.270475202960545	1	1	0.999999950762617	0.999999950762617	1
down	CYP2C9; NOS1; CYP2C19; CYP2F1; CYP2C18; CYP2U1; CYP2S1;	GO:0042738~exogenous drug catabolic process	7	25	28	0.022092113081412	0.270475202960545	1	1	0.999999950762617	0.999999950762617	1
down	KRT16; FLG; FLG2; LSR; HRNR; KDF1; TP63;	GO:0061436~establishment of skin barrier	7	25	28	0.022092113081412	0.270475202960545	1	1	0.999999950762617	0.999999950762617	1
down	MT2A; MT1A; MT1E; MT1B; MT1H; MT1M; ATP13A2;	GO:0071294~cellular response to zinc ion	7	25	28	0.022092113081412	0.270475202960545	1	1	0.999999950762617	0.999999950762617	1
down	PTPRF; FLRT3; NTNG1; GPC6; GPC4; LRFN3; LRFN4;	GO:0099560~synaptic membrane adhesion	7	25	28	0.022092113081412	0.270475202960545	1	1	0.999999950762617	0.999999950762617	1
down	PAPLN; APP; SERPINE1; SPINK8; ANOS1; SERPINB3; TFPI2; USP14; SPINK7; COL7A1; SPOCK1; WFDC2; CST9; CD109; ITIH5; SPOCK3; CSTL1; SERPINA12; SERPINB7; SERPINB4; SERPINE2; SERPINF2; SERPINB11; SERPINH1;	GO:0010951~negative regulation of endopeptidase activity	24	148	16.2162162162162	0.0221272430450981	0.270475202960545	1	1	0.999999950762617	0.999999950762617	1
down	PTPN1; WNT5A; WNT7B; MAP3K10; MAP3K12; DAB2IP; ERN2; CCL19; MAPK8IP3;	GO:0007257~activation of JUN kinase activity	9	38	23.6842105263158	0.0234195165032861	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; ABL1; APOA1; MDK; RAC3; S100A10; DOCK1; HAS2; CIB1;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	9	38	23.6842105263158	0.0234195165032861	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	ADH5; HOXA5; TCF15; CCBE1; JAG2;	GO:0003016~respiratory system process	5	14	35.7142857142857	0.0239595699848064	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; HNF4A; SRY; CDKL2; DMRT3;	GO:0007548~sex differentiation	5	14	35.7142857142857	0.0239595699848064	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	ABL1; APOE; NKX6-1; TTL; NRCAM;	GO:0030516~regulation of axon extension	5	14	35.7142857142857	0.0239595699848064	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	GNB3; RORC; HES1; ATAT1; PTPRQ;	GO:0045598~regulation of fat cell differentiation	5	14	35.7142857142857	0.0239595699848064	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	KCNK2; GJA1; CDKN1A; BMPR2; RGN;	GO:2000279~negative regulation of DNA biosynthetic process	5	14	35.7142857142857	0.0239595699848064	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; APOE; APOC1; APOA4;	GO:0010873~positive regulation of cholesterol esterification	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; HOXB1; PLXNA3; SEMA3F;	GO:0021612~facial nerve structural organization	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	COBL; SOX9; TEAD2; COL2A1;	GO:0030903~notochord development	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	KLK8; TNFRSF21; MTMR2; TMEM98;	GO:0031642~negative regulation of myelination	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	ADAMTS3; SERPINH1; TRAM2; P3H3;	GO:0032964~collagen biosynthetic process	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	FN1; CX3CL1; COL16A1; FERMT2;	GO:0033622~integrin activation	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	APOE; LCAT; APOA4; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	LDLR; APOE; APOC1; APOC3;	GO:0034382~chylomicron remnant clearance	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	WTIP; VGLL4; DLG5; AJUBA;	GO:0035331~negative regulation of hippo signaling	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; WNT3A; TGFB2; VANGL2;	GO:0048103~somatic stem cell division	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	DLL1; EFHC1; CIB1; FSD1;	GO:0051302~regulation of cell division	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	SIX1; NET1; SMO; SIX4;	GO:0051451~myoblast migration	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	BMP2; RPGRIP1L; TBX5; HEG1;	GO:0060039~pericardium development	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	HOXA5; CTNNB1; PTK7; SHH;	GO:0060484~lung-associated mesenchyme development	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	GATA4; GATA6; GATA5; SAV1;	GO:0060575~intestinal epithelial cell differentiation	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; CTNNB1; SEMA3F; FZD3;	GO:0061549~sympathetic ganglion development	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	WNT5A; LHX1; FOXA2; LRP6;	GO:0090009~primitive streak formation	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	SYT7; PLA2G5; RAB34; RAB7B;	GO:0090385~phagosome-lysosome fusion	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	HRAS; PRKCZ; GPC4; GPC6;	GO:0098696~regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	4	9	44.4444444444444	0.0245969781929616	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	MAP1B; TPPP2; CLASP1; MARK4; MTCL1; CAPN6; NCKAP5; NAV1;	GO:0001578~microtubule bundle formation	8	32	25	0.0249145898513345	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	TLX2; WNT3; ACVR1; BMPR2; EXT2; POFUT2; MESP1; MESP2;	GO:0001707~mesoderm formation	8	32	25	0.0249145898513345	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
down	KCNK2; GABRB3; GABRB2; HOXA1; HES1; RPGRIP1L; IFT27; SLITRK6;	GO:0090102~cochlea development	8	32	25	0.0249145898513345	0.282495369077558	1	1	0.999999950762617	0.999999950762617	1
up	AZU1; CCR6; CCR5; CXCR5; CXCR3; CCR10; CXCR1; CCR2; CCR8;	GO:0060326~cell chemotaxis	9	74	12.1621621621622	0.0257502480621723	0.602725423983048	1	1	0.999999999992456	0.999999999992456	1
down	NRP1; TNFRSF21; EPHB2; SEMA5A; NRCAM; CRTAC1;	GO:0007413~axonal fasciculation	6	20	30	0.0259057736164907	0.28927332002495	1	1	0.999999950762617	0.999999950762617	1
down	FGF5; EPCAM; MSX2; HNF4A; MESP1; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	6	20	30	0.0259057736164907	0.28927332002495	1	1	0.999999950762617	0.999999950762617	1
down	CAV1; DUSP4; DUSP7; SPRED2; SPRED1; DUSP10; SPRED3;	GO:0000188~inactivation of MAPK activity	7	26	26.9230769230769	0.0259117799608127	0.28927332002495	1	1	0.999999950762617	0.999999950762617	1
down	SHH; LPAR1; HDAC11; WASF3; MYRF; ZNF488; PRDM8;	GO:0014003~oligodendrocyte development	7	26	26.9230769230769	0.0259117799608127	0.28927332002495	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; DSCAM; BCL10; APP; THBS1; MIF; APLN;	GO:0042327~positive regulation of phosphorylation	7	26	26.9230769230769	0.0259117799608127	0.28927332002495	1	1	0.999999950762617	0.999999950762617	1
down	EPHB2; TGFB2; TNK1; DAB2IP; MAPKAP1; SPRY2; SPRY4;	GO:0046580~negative regulation of Ras protein signal transduction	7	26	26.9230769230769	0.0259117799608127	0.28927332002495	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; CACNB3; PRKCZ; STX1A; NLGN2; SHANK3; SHANK2;	GO:2000463~positive regulation of excitatory postsynaptic potential	7	26	26.9230769230769	0.0259117799608127	0.28927332002495	1	1	0.999999950762617	0.999999950762617	1
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0259224620726966	0.602725423983048	1	1	0.999999999992456	0.999999999992456	1
up	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0259224620726966	0.602725423983048	1	1	0.999999999992456	0.999999999992456	1
up	PF4; LTF; SEMG1; RNASE3; DEFA4; DEFA3; RNASE6; PF4V1;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.0260860661860545	0.602725423983048	1	1	0.999999999992456	0.999999999992456	1
down	WTIP; NPHP1; ITGB1; ITGA8; LRRC56; KCTD17; PIFO; RAB34; KIF17;	GO:0030030~cell projection organization	9	39	23.0769230769231	0.0265811796765201	0.296175682780302	1	1	0.999999950762617	0.999999950762617	1
up	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.0276585535094522	0.63240130159633	1	1	0.999999999992456	0.999999999992456	1
up	ORM1; BPI; NCKAP1L; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	5	29	17.2413793103448	0.0280879869112162	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	LAMA5; LRP6; TSPAN15; EPHA2; CACNB3; S100A10; STXBP1; PRKCZ; GAS6; WDR72; GPR158; TTC7B; PACS2; DPP10; MRAP; KCNB2; NKD2; MRAP2; RAB34; EHD2; KCNIP3; RAB3B; TSPAN17;	GO:0072659~protein localization to plasma membrane	23	144	15.9722222222222	0.0282330649275572	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; LPAR1; RTN4R; SYNPO2L; ROBO1; LPAR4; NET1; GPR17;	GO:0035025~positive regulation of Rho protein signal transduction	8	33	24.2424242424242	0.0285750162830466	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	SH3PXD2B; HOXD8; HOXC8; RYK; NKX3-2; TCF15; HYAL2; ANKRD11;	GO:0048705~skeletal system morphogenesis	8	33	24.2424242424242	0.0285750162830466	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
up	JCHAIN; IGKC; IGHG3; IGHA2; LTF; POTEJ;	GO:0001895~retina homeostasis	6	40	15	0.0288144498617592	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	DLL1; COBL; MEOX2;	GO:0001757~somite specification	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	PLAU; PDGFA; PLXNA1;	GO:0014910~regulation of smooth muscle cell migration	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	APOE; GPIHBP1; SNX33;	GO:0017038~protein import	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; PLXNA3; SEMA3F;	GO:0021637~trigeminal nerve structural organization	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; PLXNA3; SEMA3F;	GO:0021785~branchiomotor neuron axon guidance	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	NFIB; TSKU; NR2E1;	GO:0021960~anterior commissure morphogenesis	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	SLC12A2; P2RY6; SLC26A6;	GO:0030321~transepithelial chloride transport	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	UNC13B; RIN1; UNC13C;	GO:0031914~negative regulation of synaptic plasticity	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	APOE; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	WNT5A; DVL3; FZD10;	GO:0038031~non-canonical Wnt signaling pathway via JNK cascade	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; APOE; LCAT;	GO:0042158~lipoprotein biosynthetic process	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	SYT7; MDK; SUCO;	GO:0046850~regulation of bone remodeling	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; SHH; MSI2;	GO:0048864~stem cell development	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	SHOX2; COL2A1; HOXA11;	GO:0060351~cartilage development involved in endochondral bone morphogenesis	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; SEMA3C; PLXNA1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	FZD5; HTRA1; E2F7;	GO:0060718~chorionic trophoblast cell differentiation	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	GLI3; BAX; BAK1;	GO:0070242~thymocyte apoptotic process	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	EGR1; SOX9; SFRP1;	GO:0071504~cellular response to heparin	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	WT1; WNT7B; OSR1;	GO:0072207~metanephric epithelium development	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	WT1; LHX1; PKD2;	GO:0072284~metanephric S-shaped body morphogenesis	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	PLA2G10; SREBF2; SHH;	GO:0090370~negative regulation of cholesterol efflux	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	COL2A1; BMP5; SOX9;	GO:0097065~anterior head development	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	STXBP1; UNC13C; UNC13B;	GO:0099525~presynaptic dense core vesicle exocytosis	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	LRP5; BAX; BAK1;	GO:1902262~apoptotic process involved in blood vessel morphogenesis	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	GJB1; GJA1; GJB2;	GO:1905867~epididymis development	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	UNC5C; CTNNB1; TUBB3;	GO:1990791~dorsal root ganglion development	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	WNT5A; CSNK1E; SFRP1;	GO:2000052~positive regulation of non-canonical Wnt signaling pathway	3	5	60	0.0292961084420709	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	TGFB2; JAG1; STRA6; ROBO2; ROBO1;	GO:0003184~pulmonary valve morphogenesis	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	NFIB; FGF5; DNER; KLF15; METRN;	GO:0010001~glial cell differentiation	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	RAC3; TGFB2; CIB1; FOXC2; FERMT1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	SNAI2; DYRK3; MIF; MDM2; TWIST1;	GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	PGR; EDNRB; HES1; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	HOXA11; WNT5A; LHX1; FOXL2; TGFB2;	GO:0060065~uterus development	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	PPP2R3A; IHH; SHH; SMO; MEOX2;	GO:0061053~somite development	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	BRINP1; GLI3; NLGN4Y; SHANK3; SHANK2;	GO:0071625~vocalization behavior	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	THBS1; MEOX2; SPRED1; CARD10; STARD13;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	5	15	33.3333333333333	0.0296254862121614	0.303592280957969	1	1	0.999999950762617	0.999999950762617	1
down	FUT1; CDH13; CX3CL1; PRKCZ; SFRP1; CIB1; FERMT1;	GO:0001954~positive regulation of cell-matrix adhesion	7	27	25.9259259259259	0.0301580905094561	0.30763376128836	1	1	0.999999950762617	0.999999950762617	1
down	APLNR; NDST1; AP2B1; PTK7; MEGF8; ADAMTS6; APLN;	GO:0060976~coronary vasculature development	7	27	25.9259259259259	0.0301580905094561	0.30763376128836	1	1	0.999999950762617	0.999999950762617	1
down	FOLR1; ITGA3; IL17F; ZNF703; SMURF2; DKK3;	GO:0017015~regulation of transforming growth factor beta receptor signaling pathway	6	21	28.5714285714286	0.0308302841234938	0.311746363370895	1	1	0.999999950762617	0.999999950762617	1
down	PIK3C2A; NRP1; ABL1; KDR; CIB1; FOXC2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	6	21	28.5714285714286	0.0308302841234938	0.311746363370895	1	1	0.999999950762617	0.999999950762617	1
down	LRP6; CTNNB1; WNT3A; CAV1; FZD5; DVL3;	GO:1904886~beta-catenin destruction complex disassembly	6	21	28.5714285714286	0.0308302841234938	0.311746363370895	1	1	0.999999950762617	0.999999950762617	1
down	LAMA5; FN1; CXCL10; CSF2; ITGB1; MMP2; CSF3; GHR; SDC1; EDN2; IL11; CCND1; SHC1; NOS2; CDKN1A; LIFR; RORC; CCL11; CX3CL1; IL24; IL13RA2; TWIST1; CTF1; STX1A; FSCN1; IL31RA; IL1F10; IL22RA2; IL17F; CCL19; IL1RL2; DUOX2; IL36B; IL36G; IL36RN; IL19; IL20RA; F3; IFNE;	GO:0019221~cytokine-mediated signaling pathway	39	278	14.0287769784173	0.0311016225240881	0.313942161854645	1	1	0.999999950762617	0.999999950762617	1
up	ELANE; CCR6; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0317637062233178	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	VIL1; LMOD2; SCIN;	GO:0045010~actin nucleation	3	11	27.2727272727273	0.0317637062233178	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	ELANE; CTSG; IFNL1;	GO:0050778~positive regulation of immune response	3	11	27.2727272727273	0.0317637062233178	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	CCL24; CCL23; XCL1; XCL2;	GO:0048245~eosinophil chemotaxis	4	20	20	0.0318843013101422	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	SLITRK5; SCGB1A1; TIGAR; RHBDD3;	GO:0009410~response to xenobiotic stimulus	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	STXBP1; UNC13B; UNC13C; ZDHHC15;	GO:0016188~synaptic vesicle maturation	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	LDLR; CEL; LIMA1; NPC1L1;	GO:0030299~intestinal cholesterol absorption	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	ITGA3; TFAP2B; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	SHOX2; MDK; SIX2; PTHLH;	GO:0032330~regulation of chondrocyte differentiation	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; APOE; APOC3; APOA4;	GO:0034378~chylomicron assembly	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	TBX3; HOXD10; TFAP2B; TBX5;	GO:0035136~forelimb morphogenesis	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; MSX2; MMP12; AJUBA;	GO:0035313~wound healing, spreading of epidermal cells	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	GPR37; TH; DDC; TGFB2;	GO:0042416~dopamine biosynthetic process	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	ONECUT2; HOXD9; HOXD10; ETV1;	GO:0048935~peripheral nervous system neuron development	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	GABRB3; GABRB2; USH1C; PDZD7;	GO:0060119~inner ear receptor cell development	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	LRP4; NLGN2; NLGN4Y; CEL;	GO:0097105~presynaptic membrane assembly	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	PSCA; PATE4; SLURP1; LYPD6;	GO:0099601~regulation of neurotransmitter receptor activity	4	10	40	0.0320218076929154	0.316072152934841	1	1	0.999999950762617	0.999999950762617	1
down	ADCY6; WFS1; AQP1; AQP4; CYP4A11; ADCY2; ADCY1; TFAP2B;	GO:0003091~renal water homeostasis	8	34	23.5294117647059	0.0325899159150292	0.320044021714711	1	1	0.999999950762617	0.999999950762617	1
down	LMNA; SOX9; MDM2; SHH; SIX1; SMO; SIX4; PYGO1;	GO:0034504~protein localization to nucleus	8	34	23.5294117647059	0.0325899159150292	0.320044021714711	1	1	0.999999950762617	0.999999950762617	1
down	SLITRK5; PDGFA; COL5A2; ITGA3; TCF15; DACT2; FRAS1; TFAP2B;	GO:0043588~skin development	8	34	23.5294117647059	0.0325899159150292	0.320044021714711	1	1	0.999999950762617	0.999999950762617	1
down	SH3PXD2B; SPRY2; AGR2; PDGFB; LDLR; LMNA; FN1; CSF2; APP; REG1A; TFAP2A; INHBA; BMP2; EGR1; WT1; DRD1; CDH3; TNC; ITGA3; EPHB2; HOXD3; CDH5; WNT5A; SOX9; HMGA2; WNT3; WNT3A; MDM2; CAV1; SRY; GAS6; NR0B2; TWIST1; MAPK11; FOXD1; RBMS3; ADM2; OSR1; PIK3R3; SEC16B; SMO; GATA5; C1QTNF1; MYLK2; ATP13A2; ZNF580; ROBO1; IL1F10; IL36G; IL36B;	GO:0010628~positive regulation of gene expression	50	374	13.3689839572193	0.0329396997516445	0.32293167573778	1	1	0.999999950762617	0.999999950762617	1
down	ADCYAP1; UGT1A1; GPT; SSTR1; CPS1; FOXK2; FSTL1; TBC1D5; PCK1;	GO:0042594~response to starvation	9	41	21.9512195121951	0.0337834901326273	0.328977381224273	1	1	0.999999950762617	0.999999950762617	1
down	COBL; CYP1A1; CLDN18; FOXF1; FAT4; LGR4; ALX4;	GO:0048565~digestive tract development	7	28	25	0.0348480390556422	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
up	LTF; BTNL3; HHLA2; BTN1A1; BTNL8;	GO:0001817~regulation of cytokine production	5	31	16.1290322580645	0.0350179237053413	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	CYP27B1; SLIT3; SERPINE2; INHBA; GJA1; WT1; CDKN1A; HNF4A; TGFB2; HYAL2; TNK1; BMPR2; VGLL4; CAPRIN2; SFRP1; APBB2; DCBLD2; SOX17; NDUFA13; SH3BP4;	GO:0030308~negative regulation of cell growth	20	124	16.1290322580645	0.0358226467205329	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	CTNNB1; LHX1; WNT3; PGAP1; SIX2;	GO:0009948~anterior/posterior axis specification	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	UNC13B; STXBP1; SV2A; CADPS2; UNC13C;	GO:0016082~synaptic vesicle priming	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	PDLIM1; AQP1; RHOC; RHOBTB1; MAPKAP1;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	JUN; FOLR1; ISL1; RTN4RL1; MAPK8IP3;	GO:0031103~axon regeneration	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	MMP7; EGR1; MDK; HAS2; NCOR2;	GO:0044849~estrous cycle	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SYT7; SYT8; SYT1; RIMS4; SYT12;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	DMD; HRC; NOS1; FKBP1A; FKBP1B;	GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	DSCAM; TNN; VSTM2L; PALLD; IGSF9;	GO:0070593~dendrite self-avoidance	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	TERT; PDGFB; MDM2; DOCK7; ADAMTS1;	GO:1904754~positive regulation of vascular associated smooth muscle cell migration	5	16	31.25	0.0360673322681081	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	HOXA3; TBX1; HOXA5; HOXD3; SHH; SIX1;	GO:0030878~thyroid gland development	6	22	27.2727272727273	0.0363274261962551	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	NDST1; AP2B1; PKD2; ROBO2; ADAMTS6; ROBO1;	GO:0035904~aorta development	6	22	27.2727272727273	0.0363274261962551	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SYT1; CAV2; BVES; NDRG4; STX1A; STX2;	GO:0048278~vesicle docking	6	22	27.2727272727273	0.0363274261962551	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; BRINP1; LHX2; CCL11; WNT3A; PRTG;	GO:0050768~negative regulation of neurogenesis	6	22	27.2727272727273	0.0363274261962551	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	CYP27B1; CIB2; WFS1; REG1A; CAV1; TFAP2B;	GO:0055074~calcium ion homeostasis	6	22	27.2727272727273	0.0363274261962551	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	MGST3; HPGDS; GSTA1; GSTT2B; GSTM3; GSTA3;	GO:1901687~glutathione derivative biosynthetic process	6	22	27.2727272727273	0.0363274261962551	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
up	OXT; OPRM1; GHSR; GAST;	GO:0032094~response to food	4	21	19.047619047619	0.0364671775936334	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	TYROBP; IFNG; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.0364671775936334	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	FCGR2B; TREM2; TREML2; TREML4;	GO:0045088~regulation of innate immune response	4	21	19.047619047619	0.0364671775936334	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	JUN; ITGA2; ITGA3; SOX9; TGFB2; BMPR2; DOCK1; CLASP1;	GO:0010634~positive regulation of epithelial cell migration	8	35	22.8571428571429	0.0369721276869729	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
up	IL2RA; CTLA4; CLEC4G; LILRB2; LILRB1; PLA2G2D;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.0378551222743772	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	OXT; DBH; AVPR1A;	GO:0042711~maternal behavior	3	12	25	0.0382305333822555	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0382305333822555	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	FBLL1; PLPP4; PPP4R4; CCDC24; HS3ST6; ARHGDIG; C6orf141;	GO:0001835~blastocyst hatching	7	29	24.1379310344828	0.0399964465769781	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	CYP1A1; HSD17B1; PRLR; FDFT1; LSS; CYP51A1; TFCP2L1;	GO:0006694~steroid biosynthetic process	7	29	24.1379310344828	0.0399964465769781	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	EN2; NDST1; EN1; HES1; SHH; DLG5; LRP6;	GO:0030901~midbrain development	7	29	24.1379310344828	0.0399964465769781	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	GLI3; RAG1; CTNNB1; RAG2; FZD5; SHH; FZD8;	GO:0033077~T cell differentiation in thymus	7	29	24.1379310344828	0.0399964465769781	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	GLI3; NKX6-1; GPR17; MYRF; DUSP10; SOX9; SHH;	GO:0048709~oligodendrocyte differentiation	7	29	24.1379310344828	0.0399964465769781	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	S100A8; S100A9; SELE; CX3CL1;	GO:0002523~leukocyte migration involved in inflammatory response	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	FOXH1; WNT5A; ISL1; MESP1;	GO:0003139~secondary heart field specification	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	NME4; NME5; NME7; CTPS2;	GO:0006241~CTP biosynthetic process	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	WT1; FSHR; IRX5; OSR1;	GO:0008406~gonad development	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SOX9; HMGA2; SND1; SFRP1;	GO:0010564~regulation of cell cycle process	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SNPH; STX1A; UNC13C; UNC13B;	GO:0016081~synaptic vesicle docking	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	GLI3; CTNNB1; DAB2IP; NR2E1;	GO:0021819~layer formation in cerebral cortex	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	LDLR; APOA1; APOE; AMN;	GO:0034384~high-density lipoprotein particle clearance	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	ITGB4; ITGA2; CDSN; TP63;	GO:0043589~skin morphogenesis	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	TBX1; LHX1; NDST1; FOXC2;	GO:0048703~embryonic viscerocranium morphogenesis	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	FIGN; TTLL11; LZTS2; KATNAL1;	GO:0051013~microtubule severing	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	XPC; DDB1; DDB2; ERCC1;	GO:0070914~UV-damage excision repair	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	ADCY6; CFTR; ADCY2; ADCY1;	GO:1904322~cellular response to forskolin	4	11	36.3636363636364	0.0406168642448085	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
up	TARM1; FCN1; SIGLEC5; TYROBP; FCGR3B; TRPM2; HP; ORM1; LTF; ELANE; CTSG; RNASE2; FCGR2A; RNASE3; DEFA4; BPI; CD53; ORM2; AZU1; MMP8; FCAR; CXCR1; CEACAM8; CEACAM3; MNDA; P2RX1; HK3; NCKAP1L; SIGLEC14; CLEC12A; LILRB2; CLEC4C; MS4A3; ADGRE3; RETN; CD300A;	GO:0043312~neutrophil degranulation	36	483	7.45341614906832	0.0407517919908189	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	BMP5; ROBO2; ROBO1;	GO:0003272~endocardial cushion formation	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	TRIO; PTPRF; PTPRU;	GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	GJA1; GJB2; DBN1;	GO:0010644~cell communication by electrical coupling	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SOX1; GBX2; LHX6;	GO:0021884~forebrain neuron development	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	BMP2; LHX2; SHH;	GO:0021978~telencephalon regionalization	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	RYK; WNT3A; FZD3;	GO:0033278~cell proliferation in midbrain	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	CXCL13; CH25H; GAS6;	GO:0035754~B cell chemotaxis	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	HRAS; TH; LGALS1;	GO:0035900~response to isolation stress	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; SYT7; WNT3A;	GO:0036465~synaptic vesicle recycling	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	CSF2; EDNRB; SLC26A6;	GO:0042045~epithelial fluid transport	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	PKM; AGXT; SRR;	GO:0042866~pyruvate biosynthetic process	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	EFNA1; NF1; EPHA2;	GO:0043535~regulation of blood vessel endothelial cell migration	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SOX9; DLX1; DLX2;	GO:0046533~negative regulation of photoreceptor cell differentiation	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	INHA; INHBA; FOXL2;	GO:0046881~positive regulation of follicle-stimulating hormone secretion	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	HNF1B; LHX1; OSR1;	GO:0048793~pronephros development	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	APOC1; APOC3; ANGPTL4;	GO:0051005~negative regulation of lipoprotein lipase activity	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	TRIM32; SHH; MESP1;	GO:0051155~positive regulation of striated muscle cell differentiation	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	TMEM120B; SYT1; CALHM3;	GO:0051291~protein heterooligomerization	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	WNT3; IHH; STRA6;	GO:0060323~head morphogenesis	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	TBX1; SHOX2; PAX7;	GO:0060415~muscle tissue morphogenesis	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	HOXD13; SFRP1; HOXB13;	GO:0060527~prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SOX18; BMPR2; PROX1;	GO:0060836~lymphatic endothelial cell differentiation	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	WNT7A; WNT9B; STRA6;	GO:0061038~uterus morphogenesis	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	LRP5; COL4A1; LAMA1;	GO:0061304~retinal blood vessel morphogenesis	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	EPHA2; PROX1; ABI2;	GO:0070309~lens fiber cell morphogenesis	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	WT1; GATA6; SLC5A5;	GO:0071371~cellular response to gonadotropin stimulus	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	PFN2; WASF1; WASF3;	GO:0098885~modification of postsynaptic actin cytoskeleton	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	C1QL1; CBLN1; DCTN1;	GO:0099558~maintenance of synapse structure	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	APLP1; MRAP; MRAP2;	GO:0106072~negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	NRP1; FN1; SEMA3F;	GO:1901166~neural crest cell migration involved in autonomic nervous system development	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	GPC6; GPC1; GPC4;	GO:1905475~regulation of protein localization to membrane	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SNAI2; KDF1; FERMT1;	GO:2000647~negative regulation of stem cell proliferation	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	TBX1; SOX9; SHH;	GO:2001054~negative regulation of mesenchymal cell apoptotic process	3	6	50	0.0410375012823546	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	APOA1; PKM; UGT1A1; AXL; CDKN1A; GAS6; NR0B2; BAK1; PTPRU;	GO:0031100~animal organ regeneration	9	43	20.9302325581395	0.0422277660116367	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	GLI2; GLI3; HOXA11; KDF1; DMBX1; STRA6;	GO:0048589~developmental growth	6	23	26.0869565217391	0.0424143703630936	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	APOE; ITSN1; DLG5; LPAR1; SHANK3; SHANK2;	GO:0060999~positive regulation of dendritic spine development	6	23	26.0869565217391	0.0424143703630936	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
up	GPR55; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	5	33	15.1515151515152	0.042915980004176	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	COL12A1; COL7A1; SCARA3; MATN3; VWA2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	5	17	29.4117647058824	0.0433051934156216	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	SLC16A2; DIO3; IYD; SLC5A5; DUOX2;	GO:0006590~thyroid hormone generation	5	17	29.4117647058824	0.0433051934156216	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	WFS1; BAX; BAK1; PACS2; KCTD17;	GO:0032469~endoplasmic reticulum calcium ion homeostasis	5	17	29.4117647058824	0.0433051934156216	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	TH; NEFL; FOSL1; CCND1; CDKN1A;	GO:0051412~response to corticosterone	5	17	29.4117647058824	0.0433051934156216	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	DCLK1; CLDN18; LZTS2; TMEM98; MAGED1;	GO:1900181~negative regulation of protein localization to nucleus	5	17	29.4117647058824	0.0433051934156216	0.332174612404087	1	1	0.999999950762617	0.999999950762617	1
down	ZNF320; ZNF840P; ZNF98; ZFP92; ZNF726; ZNF785; ZNF727; ZNF732; KRBOX1; SOX1; ZSCAN9; SOX15; FADS1; LMX1B; ABL1; HOXB7; ZNF728; BMP2; HOXB1; ZKSCAN1; ZNF37A; WT1; HOXD13; GATA4; ZNF84; HMGA2; ESRRG; FOXK2; BNC1; SOX4; ZNF616; MN1; EFEMP1; ELAVL2; SNAPC2; HIC1; SIX1; TEAD2; ZFHX3; ZNF74; ZNF699; ZNF528; ZSCAN23; ZNF667; ZNF311; ZNF470; ZNF449; ZBED9; ZNF621; ZSCAN2; ZNF329; ZNF677; ZNF561; IGSF1; ZNF676; ZNF610; L3MBTL4; ZNF114; MAFA; ZFP28; ZNF596; TFAP2B; APBB2; USP13; L3MBTL3; PGBD1; ZNF587; VGLL1; ZNF471; SOX17; ZNF703; TLE6; TCF7L1; PAK6; ZFP57; ZIM2; ZNF492; ZFP69B; ZNF391; ZNF112; ZNF229; ZNF214; MAPK8IP1; ZKSCAN5; MAGED1; ZFP37; SRY; ZNF423; HMGB1P1; HMGB3; SALL2; AJUBA; SOX12; SNAI2; WTIP; SOX7; SPIN1; SOX18; WIZ;	GO:0006355~regulation of transcription, DNA-templated	99	824	12.0145631067961	0.0443227021343761	0.338793847185455	1	1	0.999999950762617	0.999999950762617	1
up	CEACAM4; ICAM3; IRF8; SLAMF1; CEBPE; PLD4; ELANE;	GO:0006909~phagocytosis	7	57	12.280701754386	0.0443421373940465	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	JCHAIN; IGKV3-20; IGHA2;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.0453112611795006	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0453112611795006	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
up	SPTA1; VIL1; SCIN;	GO:0051693~actin filament capping	3	13	23.0769230769231	0.0453112611795006	0.633705896404785	1	1	0.999999999992456	0.999999999992456	1
down	JUN; HMGA2; ZFP90; HDAC2; ZNF462; MDFI; SMO;	GO:0043392~negative regulation of DNA binding	7	30	23.3333333333333	0.0456158253356992	0.346847889757272	1	1	0.999999950762617	0.999999950762617	1
down	PIK3C2A; NRP1; PDGFB; PDGFA; BCAR1; CSPG4; PLAT;	GO:0048008~platelet-derived growth factor receptor signaling pathway	7	30	23.3333333333333	0.0456158253356992	0.346847889757272	1	1	0.999999950762617	0.999999950762617	1
down	KCNK2; APOD; LGALS1; BAX; DPYSL3; MORN4; FLRT3;	GO:0048678~response to axon injury	7	30	23.3333333333333	0.0456158253356992	0.346847889757272	1	1	0.999999950762617	0.999999950762617	1
down	AGRN; NRP1; DPYSL3; FSCN1; PLPPR5; FNBP1L; TENM2;	GO:0051491~positive regulation of filopodium assembly	7	30	23.3333333333333	0.0456158253356992	0.346847889757272	1	1	0.999999950762617	0.999999950762617	1
down	ZDHHC1; ZDHHC16; ZDHHC15; ZDHHC8; ZDHHC9; HHAT;	GO:0018345~protein palmitoylation	6	24	25	0.0491042389632025	0.369014216021784	1	1	0.999999950762617	0.999999950762617	1
down	ONECUT2; SOX9; SOX4; BAK1; FOXA2; MNX1;	GO:0031018~endocrine pancreas development	6	24	25	0.0491042389632025	0.369014216021784	1	1	0.999999950762617	0.999999950762617	1
down	DLL1; TBX3; CXCL10; SOX9; SOSTDC1; CCL17;	GO:0045662~negative regulation of myoblast differentiation	6	24	25	0.0491042389632025	0.369014216021784	1	1	0.999999950762617	0.999999950762617	1
